
(
  (S
    (NP
      (NP (DT A) (NN role))
      (PP (IN for)
        (NP (DT the) (NN Tec) (NN family) (NN kinase) (NN ITK)))
      (PP (IN in)
        (S
          (VP (VBG regulating)
            (NP (NN SEB) (JJ induced) (NN Interleukin-2) (NN production))
            (ADVP (FW in) (FW vivo))
            (PP (IN via)
              (NP (NN c-jun) (NN phosphorylation)))))))))

(
  (S
    (NP (NN Abstract))))

(
  (S
    (NP
      (NP (NN Background))
      (: :)
      (S
        (NP
          (NP (NN Exposure))
          (PP (TO to)
            (NP
              (NP
                (NP (JJ Staphylococcal) (NN Enterotoxin) (NN B))
                (PRN (-LRB- -LRB-)
                  (NP (NN SEB))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (DT a) (JJ bacterial) (NN superantigen))
                (VP (VBN secreted)
                  (PP (IN by)
                    (NP (DT the) (JJ Gram-positive) (NNS bacteria)))
                  (ADVP (FW Staphyloccocus) (FW aureus))))
              (, ,))))
        (VP (VBZ results)
          (PP (IN in)
            (NP
              (NP
                (NP (DT the) (NN expansion))
                (CC and)
                (NP
                  (NP
                    (NP (JJ eventual) (JJ clonal) (NN deletion))
                    (CC and)
                    (NP (NN anergy)))
                  (PP (IN of)
                    (NP (NN Vβ8+) (NN T) (NNS cells)))))
              (, ,)
              (CONJP (RB as) (RB well) (IN as))
              (NP (JJ massive) (NN cytokine) (NN release))
              (, ,)
              (PP (VBG including)
                (NP
                  (NP (NN Interleukin-2))
                  (PRN (-LRB- -LRB-)
                    (NP (NN IL-2))
                    (-RRB- -RRB-))))))))
      (. .))))

(
  (S
    (S
      (NP (DT This) (NN IL-2))
      (VP
        (VP (VBZ is)
          (ADVP (RB rapidly))
          (VP (VBN secreted)
            (PP (VBG following)
              (NP
                (NP (NN exposure))
                (PP (TO to)
                  (NP (NN SEB)))))))
        (CC and)
        (VP (MD may)
          (VP (VB contribute)
            (PP (TO to)
              (NP
                (NP (DT the) (NNS symptoms))
                (VP (VBN seen)
                  (PP (VBG following)
                    (NP
                      (NP (NN exposure))
                      (PP (TO to)
                        (NP (DT this) (JJ bacterial) (NN toxin))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The)
        (NP (NN Tec) (NN family) (NN kinase))
        (NN ITK))
      (VP
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN shown)
              (S
                (VP (TO to)
                  (VP (VB be)
                    (ADJP (JJ important)
                      (PP (IN for)
                        (NP
                          (NP (DT the) (NN production))
                          (PP (IN of)
                            (NP (NN IL-2)))
                          (PP (IN by)
                            (NP
                              (NP (NN T) (NNS cells))
                              (VP (VBN stimulated)
                                (ADVP (FW in) (FW vitro))))))))))))))
        (CC and)
        (VP (MD may)
          (VP (VB represent)
            (NP
              (NP (DT a) (JJ good) (NN target))
              (PP (IN for)
                (S
                  (VP (VBG blocking)
                    (NP
                      (NP (DT the) (NN production))
                      (PP (IN of)
                        (NP (DT this) (NN cytokine))))
                    (ADVP (FW in) (FW vivo))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN In) (NN order)
        (S
          (VP (TO to)
            (VP (VB determine)
              (SBAR (IN if)
                (S
                  (NP (NN ITK))
                  (VP (VBZ represents)
                    (NP (PDT such) (DT a) (NN target)))))))))
      (, ,)
      (NP
        (NP (NNS mice))
        (VP (VBG lacking)
          (NP (NN ITK))))
      (VP (VBD were)
        (VP (VBN analyzed)
          (PP (IN for)
            (NP
              (NP (PRP$ their) (NN response))
              (PP (TO to)
                (NP (NN SEB) (NN exposure))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Results))
      (: :)
      (S
        (NP (PRP It))
        (VP (VBD was)
          (VP (VBN found)
            (SBAR (IN that)
              (S
                (NP
                  (NP (NN T) (NNS cells))
                  (PP (IN from)
                    (NP
                      (NP (NNS mice))
                      (VP (VBG lacking)
                        (NP (NN ITK))))))
                (VP (VBD exhibited)
                  (NP
                    (NP
                      (ADJP (RB significantly) (VBN reduced))
                      (JJ proliferative) (NNS responses))
                    (PP (TO to)
                      (NP (NN SEB) (NN exposure))))
                  (ADVP
                    (ADVP (FW in) (FW vitro))
                    (, ,)
                    (CONJP (RB as) (RB well) (IN as))
                    (ADVP (FW in) (FW vivo)))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NN Examination))
        (PP (IN of)
          (NP (NN IL-2) (NN production))))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP (NN ITK) (JJ null) (NNS mice))
            (VP (VBD produced)
              (NP
                (NP (VBN reduced) (NNS levels))
                (PP (IN of)
                  (NP (DT this) (NN cytokine))))
              (ADVP (FW in) (FW vitro))
              (, ,)
              (ADVP (CC and)
                (ADVP (RBR more) (RB dramatically)))
              (, ,)
              (PP (IN in)
                (NP (FW vivo))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (ADJP (FW In) (FW vivo))
          (NN analysis))
        (PP (IN of)
          (NP
            (NP (NN c-jun) (NN phosphorylation))
            (, ,)
            (VP
              (ADVP (RB previously))
              (VBN shown)
              (S
                (VP (TO to)
                  (VP (VB be)
                    (ADJP (JJ critical)
                      (PP (IN for)
                        (S
                          (VP (VBG regulating)
                            (NP (NN IL-2) (NN production))))))))))
            (, ,))))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP (DT this) (NN pathway))
            (VP (VBD was)
              (ADVP (RB specifically))
              (VP (VBN activated)
                (PP
                  (PP (IN in)
                    (NP
                      (NP
                        (NP
                          (NP (NN SEB) (JJ reactive) (NN Vβ8+))
                          (PRN (-LRB- -LRB-)
                            (CONJP (CC but)
                              (RB not))
                            (NP (JJ non-reactive) (NN Vβ6+))
                            (-RRB- -RRB-)))
                        (NN T) (NNS cells))
                      (PP (IN from)
                        (NP (JJ WT) (NNS mice)))))
                  (, ,)
                  (CC but)
                  (PP (RB not) (IN in)
                    (NP
                      (NP (JJ Vβ8+) (NN T) (NNS cells))
                      (PP (IN from)
                        (NP (NN ITK) (JJ null) (NNS mice))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (NN toxicity) (NN analysis))
      (VP (VBD indicated)
        (SBAR (IN that)
          (S
            (NP
              (NP (CC both)
                (NP (NN WT))
                (CC and)
                (NP (NN ITK)))
              (JJ null) (NNS animals))
            (VP (VBD were)
              (ADVP (RB similarly))
              (VP (VBN affected)
                (PP (IN by)
                  (NP (NN SEB) (NN exposure)))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Conclusion))
      (: :)
      (S
        (NP (DT These) (NNS data))
        (VP (VBP show)
          (SBAR (IN that)
            (S
              (NP (NN ITK))
              (VP
                (VP (VBZ is)
                  (VP (VBN required)
                    (PP (IN for)
                      (NP
                        (NP (NN IL-2) (NN production))
                        (VP (VBN induced)
                          (PP (IN by)
                            (NP (NN SEB)))
                          (ADVP (FW in) (FW vivo)))))))
                (, ,)
                (CC and)
                (VP (MD may)
                  (VP (VB regulate)
                    (NP
                      (NP (NNS signals))
                      (VP (VBG leading)
                        (NP (NN IL-2) (NN production))))
                    (, ,)
                    (PP (IN in)
                      (NP (NN part)))
                    (PP (IN by)
                      (S
                        (VP (VBG regulating)
                          (NP
                            (NP (NN phosphorylation))
                            (PP (IN of)
                              (NP (NN c-jun))))))))))))))
      (. .))))

(
  (S
    (S
      (NP (DT The) (NNS data))
      (ADVP (RB also))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (S
              (VP (VBG perturbing)
                (NP
                  (NP (NN T) (NN cell) (NN activation) (NNS pathways))
                  (VP (VBG leading)
                    (PP (TO to)
                      (NP (NN IL-2)))))))
            (VP (VBZ does) (RB not)
              (ADVP (RB necessarily))
              (VP (VB lead)
                (PP (TO to)
                  (NP
                    (NP (JJ improved) (NNS responses))
                    (PP (TO to)
                      (NP (NN SEB) (NN toxicity)))))))))))
    (. .)))

(
  (S
    (NP (NN Background))))

(
  (S
    (S
      (NP
        (NP (NNS Superantigens))
        (PRN (-LRB- -LRB-)
          (NP (NNS SAGs))
          (-RRB- -RRB-)))
      (VP (VBP are)
        (NP
          (NP (JJ microbial) (NNS toxins))
          (PP (IN of)
            (NP
              (ADJP
                (ADJP (JJ bacterial))
                (CC and)
                (ADJP (JJ viral)))
              (NN origin))))
        (PP (IN with)
          (NP (DT the) (NN ability)
            (S
              (VP (TO to)
                (VP (VB activate)
                  (NP
                    (NP (CD 5–20) (NN %))
                    (PP (IN of)
                      (NP (DT the) (NN T) (NN cell) (NN population)))))))))
        (, ,)
        (S
          (VP (VBG causing)
            (NP
              (NP (NN T) (NN cell) (NN activation))
              (, ,)
              (NP (NN cytokine) (NN release))
              (CC and)
              (NP (JJ systemic) (NN shock) (NN -LSB-1,2))))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (NP (JJS Most) (NNS SAGs))
    (VP (VBP share)
      (NP
        (NP
          (NP (DT the) (NN ability))
          (S
            (VP (TO to)
              (ADVP (RB simultaneously))
              (VP (VB bind)
                (NP (DT the) (NN class) (CD II) (JJ major) (NN histocompatibility) (NN complex) (NNS molecules))))))
        (CC and)
        (NP
          (NP (DT the) (JJ variable) (NN region))
          (PP (IN of)
            (NP (DT the) (NN T) (NN cell) (NN receptor) (NN β-chain)))))
      (, ,)
      (PP (IN without)
        (NP (DT the) (NN need)
          (S
            (VP (TO to)
              (VP (VB be)
                (VP (VBN processed)
                  (PP (IN by)
                    (NP
                      (NP (NN antigen) (NN presenting) (NNS cells))
                      (PRN (NN -LSB-1,2) (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (ADVP (RB Thus))
    (NP (NN SEB))
    (VP (MD can)
      (VP
        (VP (VB interact)
          (ADVP (RB directly))
          (PP (IN with)
            (NP
              (NP (NN MHC) (NN class) (CD II) (NNS molecules))
              (PP (IN on)
                (NP (NNS APCs))))))
        (CC and)
        (VP (VB activate)
          (NP
            (NP (NN T) (NNS cells))
            (VP (VBG bearing)
              (NP (DT the) (JJ proper) (NN TcR) (NN Vβ) (NNS chains)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN result))
        (PP (IN of)
          (NP (DT this) (NN interaction))))
      (VP (VBZ is)
        (NP
          (NP (JJ large-scale) (NN stimulation))
          (PP (IN of)
            (NP
              (NP (DT any) (NN T) (NN cell))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBZ expresses)
                    (NP (DT the) (JJ proper) (NN TCR) (NN Vβ) (NN chain))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NN number))
        (PP (IN of)
          (NP (NNS studies))))
      (VP (VBP have)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (SBAR
                (WHADVP (WRB when))
                (S
                  (NP (NNS mice))
                  (VP (VBP are)
                    (VP (VBN challenged)
                      (PP (IN with)
                        (NP
                          (NP (DT a) (NN SAG))
                          (PP (JJ such) (IN as)
                            (NP
                              (NP (JJ Staphylococcal) (NN Enterotoxin) (NN B))
                              (PRN (-LRB- -LRB-)
                                (NP (NN SEB))
                                (-RRB- -RRB-))))))))))
              (, ,)
              (NP (NN toxicity))
              (VP (VBZ results)
                (PP (IN from)
                  (NP
                    (NP (JJ massive) (NN induction))
                    (PP (IN of)
                      (NP
                        (NP (NNS cytokines))
                        (VP (VBN derived)
                          (PP (IN from)
                            (NP
                              (NP (NN T-helper-type-1) (-LRB- -LRB-) (NN TH1) (-RRB- -RRB-) (NN type) (NNS cells))
                              (PP (JJ such) (IN as)
                                (NP
                                  (NP (NN IL-2))
                                  (, ,)
                                  (NP (NN IFN-γ))
                                  (, ,)
                                  (NP (NN TNF-α))
                                  (CC and)
                                  (NP (JJ TNF-β) (NN -LSB-1,3))))))))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN cytokine) (NN production))
      (VP (VBZ is)
        (VP (VBN accompanied)
          (PP (IN by)
            (NP
              (NP (NN expansion))
              (PP (IN of)
                (NP
                  (NP (DT the) (NNS numbers))
                  (PP (IN of)
                    (NP (NN SEB) (JJ reactive) (NN T) (NNS cells)))))))
          (, ,)
          (S
            (VP (VBN followed)
              (PP (IN by)
                (NP
                  (NP (NN cell) (NN death))
                  (CC and)
                  (NP
                    (NP (DT the) (NN induction))
                    (PP (IN of)
                      (NP (JJ functional) (`` ``) (NN anergy) (NN '') (CD -LSB-4-6) (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN order)))
    (SBAR (IN for)
      (S
        (NP (DT a) (NN T) (NN cell))
        (VP (TO to)
          (VP (VB be)
            (VP (VBN activated)
              (NP
                (NP (NN antigen) (NN presenting) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NN APC))
                  (-RRB- -RRB-))))))))
    (VP (MD must)
      (VP (VB present)
        (NP (NN antigen))
        (, ,)
        (UCP (CC either)
          (NP (DT an) (JJ antigenic) (NN peptide))
          (CC or)
          (ADJP (JJ SAG)))))
    (. .)))

(
  (S
    (S
      (ADVP (FW In) (FW vitro))
      (, ,)
      (NP
        (NP (DT this) (NN interaction))
        (PP (IN with)
          (NP (DT the) (NN TcR))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB lead)
                  (PP (TO to)
                    (NP
                      (NP (DT the) (NN activation))
                      (PP (IN of)
                        (NP
                          (NP (DT a) (NN number))
                          (PP (IN of)
                            (NP
                              (NP (NN tyrosine) (NNS kinases))
                              (, ,)
                              (PP (VBG including)
                                (NP
                                  (NP (DT the) (NN Src) (NN family) (NN kinase) (NN Lck))
                                  (, ,)
                                  (NP (DT the) (NN Syk) (NN family) (NN kinase) (NN Zap-70))
                                  (CC and)
                                  (NP
                                    (NP (DT the) (NN Tec) (NN family) (NN kinase) (NN ITK))
                                    (PRN (-LRB- -LRB-)
                                      (SBAR (IN for)
                                        (S
                                          (NP (NN review))
                                          (VP (VB see)
                                            (NP (CD -LSB-7-10) (-RRB- -RSB-)))))
                                      (-RRB- -RRB-))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (ADVP (RB then))
      (VP (VBZ results)
        (PP (IN in)
          (NP
            (NP (DT the) (NN activation))
            (PP (IN of)
              (NP
                (NP (DT a) (NN number))
                (PP (IN of)
                  (NP
                    (NP (NN signaling) (NNS pathways))
                    (PP (VBG including)
                      (NP
                        (NP (NNS members))
                        (PP (IN of)
                          (NP
                            (NP (DT the) (NN MAPK) (NN family))
                            (PP (IN of)
                              (NP
                                (NP (NNS kinases))
                                (, ,)
                                (NP
                                  (NP (NN ERK))
                                  (, ,)
                                  (NP (NN JNK))
                                  (CC and)
                                  (NP (NN p38)))))))))))))))
        (, ,)
        (S
          (VP (VBN followed)
            (PP (IN by)
              (NP (NN transcription) (NN factor) (NN activation) (CD -LSB-10))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (ADVP (FW In) (FW vivo))
      (, ,)
      (NP
        (NP (NN activation))
        (PP (IN of)
          (NP (DT these) (NN T) (NNS cells))))
      (VP (VBD lead)
        (PP (TO to)
          (NP
            (NP (DT the) (NN induction))
            (PP (IN of)
              (NP (NN cytokine) (NN secretion)))
            (PP (IN within)
              (NP
                (NP (NNS hours))
                (PP (IN of)
                  (NP (NN SEB) (NN exposure) (CD -LSB-1,3))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (NN ITK))
      (VP (VBZ is)
        (VP (VBN expressed)
          (ADVP (RB primarily))
          (PP (IN in)
            (NP
              (NP (NN T) (NNS cells))
              (, ,)
              (NP (NN NK) (NNS cells))
              (CC and)
              (NP (NN mast) (NNS cells) (CD -LSB-11-13))))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN T) (NNS cells)))
      (, ,)
      (NP (PRP it))
      (VP (VBZ is)
        (ADVP (RB rapidly))
        (VP (VBN activated)
          (PP (VBG following)
            (NP (NN TcR) (NN crosslinking)))
          (PP (IN in)
            (NP (FW vitro) (NN -LSB-14,15) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Mice))
        (VP (VBG lacking)
          (NP (NN ITK))))
      (VP (VBP exhibit)
        (NP
          (NP
            (NP
              (NP (VBN reduced) (NN proliferation))
              (CC and)
              (NP (NN IL-2) (NN production)))
            (ADVP (FW in) (FW vitro)))
          (, ,)
          (CC and)
          (NP (VBN reduced) (NN T) (NN cell) (NN differentiation)))
        (ADVP
          (ADVP (FW in) (FW vitro))
          (CC and)
          (ADVP (FW in) (FW vivo)))
        (, ,)
        (SBAR (IN with)
          (S
            (NP (NN TH2) (NN cell) (NN differentiation))
            (ADVP (RB preferentially))
            (VP (VBD affected)
              (NP (NN -LSB-15-19)))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (VBN observed) (VBN reduced) (NN proliferation))
        (PP (IN of)
          (NP (NN ITK) (NN null) (NN T) (NNS cells)))
        (ADVP (FW in) (FW vitro)))
      (VP (VBZ is)
        (ADJP (NN IL-2) (JJ dependent))
        (SBAR (IN as)
          (S
            (NP (PRP it))
            (VP (MD could)
              (VP (VB be)
                (VP (VBN rescued)
                  (PP (IN by)
                    (NP
                      (NP (DT the) (NN addition))
                      (PP (IN of)
                        (NP (JJ exogenous) (NN IL-2) (CD -LSB-20))))))))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (DT these) (NNS animals))
      (VP (VBP are) (RB not)
        (ADVP (RB entirely))
        (VP (VBN immunocompromised) (, ,)
          (PP (IN with)
            (NP
              (NP (JJ residual) (NNS responses))
              (PP (IN against)
                (NP
                  (NP (NN LCM))
                  (, ,)
                  (NP (NN Vaccinia))
                  (CC and)
                  (NP (CC VS)
                    (NP (NNS viruses))
                    (CD -LSB-21) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN tested)
          (SBAR (IN whether)
            (S
              (NP (NN ITK) (JJ null) (NNS mice))
              (VP (VBP are)
                (ADJP (JJ susceptible)
                  (PP (TO to)
                    (NP (NN SEB) (JJ induced) (NN IL-2) (NN secretion))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP show)
        (ADVP (RB here))
        (SBAR (IN that)
          (S
            (NP
              (NP (NNS mice))
              (VP (VBG lacking)
                (NP (NN ITK))))
            (VP (VBP have)
              (NP
                (NP
                  (ADJP (RB much) (VBN reduced))
                  (NN IL-2) (NN production))
                (CC and)
                (NP (NN T) (NN cell) (NN expansion)))
              (PP (IN in)
                (NP
                  (NP (NN response))
                  (PP (TO to)
                    (NP (NN SEB)))
                  (ADVP
                    (ADVP (FW in) (FW vitro))
                    (CC and)
                    (ADVP (FW in) (FW vivo))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB also))
      (VP (VBP show)
        (SBAR
          (SBAR (IN that)
            (S
              (NP (NN SEB))
              (VP (VBD induced)
                (NP
                  (NP (DT the) (NN activation))
                  (PP (IN of)
                    (NP (DT the) (NN JNK) (NN MAPK) (NN pathway)))
                  (PP (IN in)
                    (NP (VBG responding) (NN T) (NNS cells))))
                (ADVP (FW in) (FW vivo)))))
          (, ,)
          (CC and)
          (SBAR (IN that)
            (S
              (NP (NN ITK) (NN null) (NN T) (NNS cells))
              (VP (VBD were)
                (ADJP (JJ defective)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN activation))
                      (PP (IN of)
                        (NP (DT this) (NN pathway)))
                      (ADVP (FW in) (FW vivo)))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (NN toxicity) (NN analysis))
      (VP (VBD indicated)
        (SBAR (IN that)
          (S
            (NP
              (NP (CC both)
                (NP (NN WT))
                (CC and)
                (NP (NN ITK)))
              (JJ null) (NNS animals))
            (VP (VBD were)
              (ADVP (RB similarly))
              (VP (VBN affected)
                (PP (IN by)
                  (NP (NN SEB) (NN exposure)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS data))
      (VP (VBP suggest)
        (SBAR
          (SBAR (IN that)
            (S
              (NP (NN ITK))
              (VP (VBZ is)
                (VP (VBN required)
                  (PP (IN for)
                    (NP
                      (NP (JJ full) (NN IL-2) (NN secretion))
                      (PP (VBG following)
                        (NP (NN SEB) (NN exposure)))))))))
          (, ,)
          (CC and)
          (SBAR (IN that)
            (S
              (NP (DT this))
              (VP (MD may)
                (VP (VB be)
                  (ADJP (JJ due)
                    (PP (TO to)
                      (NP
                        (NP (DT the) (NN regulation))
                        (PP (IN of)
                          (NP (DT the) (NN JNK) (NN pathway)))
                        (PP (IN by)
                          (NP (NN ITK)))))
                    (ADVP (FW in) (FW vivo))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (S
        (VP (VBG reducing)
          (NP (NN T) (NN cell) (NNS signals))))
      (VP (VBZ does) (RB not)
        (ADVP (RB necessarily))
        (VP (VB lead)
          (PP (TO to)
            (NP
              (NP
                (ADJP (RBR better) (JJ physiological))
                (NNS responses))
              (PP (TO to)
                (NP (NN SEB) (NN exposure))))))))
    (. .)))

(
  (S
    (NP (NNS Results))))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ has)
        (ADVP (RB previously))
        (VP (VBN been)
          (VP (VBN reported)
            (SBAR (IN that)
              (S
                (NP
                  (NP (NN T) (NNS cells))
                  (PP (IN from)
                    (NP
                      (NP (NNS mice))
                      (VP (VBG lacking)
                        (NP (NN ITK))))))
                (VP (VBP exhibit)
                  (NP
                    (ADJP (RB much) (VBN reduced))
                    (NN proliferation))
                  (PP (IN in) (NN response) (TO to)
                    (NP
                      (NP
                        (ADJP (JJ anti-CD3)))
                      (CC or)
                      (NP (NN TcR) (NNS antibodies))
                      (NP
                        (ADJP (FW in) (FW vitro))
                        (NN -LSB-15,16,18)))))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN By)
        (NP (NN contrast)))
      (, ,)
      (NP (DT these) (NN T) (NNS cells))
      (VP
        (VP (VBD did) (RB not)
          (VP (VB have)
            (NP (DT any) (NNS defects))))
        (CC and)
        (ADVP (RB actually))
        (VP (VBD had)
          (NP (JJR higher) (JJ proliferative) (NNS responses))
          (PP (VBG following)
            (NP (NN anti-CD28/PMA) (NN stimulation) (CD -LSB-20)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS data))
      (VP (VBP do) (RB not)
        (VP (VB provide)
          (NP (JJ clear) (NNS answers))
          (PP (IN as) (TO to)
            (SBAR (IN whether)
              (S
                (NP (NN ITK))
                (VP (MD would)
                  (VP (VB present)
                    (NP
                      (NP (DT a) (JJ good) (NN target))
                      (PP
                        (PP (IN for)
                          (NP
                            (NP (NN inhibition))
                            (PP (IN of)
                              (NP
                                (NP (NN SEB))
                                (VP (VBD induced)
                                  (NP (NN T) (NN cell) (NN activation))
                                  (ADVP (FW in) (FW vivo)))))))
                        (, ,)
                        (CC and)
                        (PP (IN in)
                          (NP (JJ particular)))))
                    (, ,)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN cytokine) (NN response))
                        (VP (VBN observed)
                          (PP (VBG following)
                            (NP (NN SAG) (NN exposure))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB therefore))
      (ADVP (RB first))
      (VP (VBD tested)
        (SBAR (IN whether)
          (S
            (NP (NN ITK) (NN null) (NN T) (NNS cells))
            (VP (MD could)
              (VP (VB respond)
                (PP (TO to)
                  (NP
                    (NP (NN SEB) (NN stimulation))
                    (PP (IN by)
                      (NP (NN proliferation)))))
                (ADVP (FW in) (FW vitro))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP
            (NP (JJ Pooled) (NNS splenocytes))
            (CC and)
            (NP
              (NP (NN lymph) (NN node))
              (NNS cells)))
          (PP (IN from)
            (NP
              (NP
                (NP (NN WT))
                (CC or)
                (NP (NN ITK)))
              (JJ null) (NNS animals))))
        (VP (VBD were)
          (VP (VBN cultured)
            (ADVP (FW in) (FW vitro))
            (PP (IN in)
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP
                    (NP (JJ varying) (NNS concentrations))
                    (PP (IN of)
                      (NP
                        (NP (NN SEB))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (CD 5) (NN μg/ml))
                            (, ,)
                            (NP (CD 0.5) (NN μg/ml))
                            (, ,)
                            (NP (CD 0.05) (NN μg/ml))
                            (, ,)
                            (NP (CD 0.005) (NN μg/ml))
                            (, ,)
                            (CC and)
                            (NP (CD 0.0005) (NN μg/ml)))
                          (-RRB- -RRB-)))))))))))
      (, ,)
      (CC and)
      (S
        (NP (NN proliferation))
        (VP (VBN analyzed)
          (PP (IN over)
            (NP (DT a) (JJ 5-day) (NN period))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD found)
        (SBAR (IN that)
          (S
            (NP (NN WT) (NNS cells))
            (VP (VBD responded)
              (ADVP (RB normally))
              (PP (IN by)
                (S
                  (VP (VBG proliferating)
                    (PP (IN between)
                      (NP (NNS days) (CD 2)
                        (CC and)
                        (CD 3))))))
              (, ,)
              (PP (IN with)
                (NP
                  (NP (JJ maximum) (NN proliferation))
                  (VP (VBN observed)
                    (PP (IN at)
                      (NP
                        (NP (NN day) (CD 5))
                        (CC and)
                        (NP
                          (NP
                            (NP (DT the)
                              (ADJP (CD 5) (NN μg/ml))
                              (NN dose))
                            (PP (IN of)
                              (NP (NN SEB))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP Fig.) (NN 1a))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Analysis))
        (PP (IN of)
          (NP
            (NP (DT the) (NN dose) (NN response))
            (PP (IN at)
              (NP (CD 5) (NNS days))))))
      (VP (VBD indicated)
        (SBAR (IN that)
          (S
            (NP (DT the) (JJ WT) (NNS cells))
            (VP (VBD responded)
              (PP (IN in)
                (NP (DT a)
                  (ADJP (NN dose) (JJ dependent))
                  (NN fashion)))
              (PRN (-LRB- -LRB-)
                (NP (NNP Fig.) (NN 1b))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN By)
        (NP (NN contrast)))
      (, ,)
      (NP
        (NP (NNS cells))
        (PP (IN from)
          (NP (NN ITK) (NNS mice))))
      (VP (VBD showed)
        (NP
          (ADJP (RB very) (JJ little))
          (NN response))
        (, ,)
        (ADVP (RB regardless)
          (PP (IN of)
            (NP
              (NP (DT the) (NN dose))
              (PP (IN of)
                (NP (NN SEB)))
              (VP (VBN used)
                (PP (IN for)
                  (NP
                    (NP (NN stimulation))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP
                          (NP (NNP Fig.))
                          (NP (NN 1a)))
                        (, ,)
                        (NP (NN b)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB next))
      (VP (VBD determined)
        (SBAR (IN if)
          (S
            (NP (DT the) (JJ same) (NNS results))
            (VP (MD would)
              (VP (VB be)
                (VP (VBN obtained)
                  (PP (IN in)
                    (NP
                      (NP (VBN purified) (NN T) (NN cell) (NNS populations))
                      (PP (IN from)
                        (NP (DT these) (NNS mice))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN T) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN purified)
            (PP (IN from)
              (NP
                (NP
                  (NP (NN WT))
                  (CC and)
                  (NP (NN ITK)))
                (JJ null) (NNS mice))))
          (, ,)
          (CC and)
          (VP (VBN stimulated)
            (PP (IN with)
              (NP
                (NP (JJ varying) (NN dose))
                (PP (IN of)
                  (NP (NN SEB))))))
          (, ,)
          (PP (IN in)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (NNS APCs))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Analysis))
      (PP (IN of)
        (NP
          (NP (DT the) (NNS data))
          (PP (IN over)
            (NP (DT the) (CD 5) (NNS days))))))
    (VP (VBD indicated)
      (SBAR (IN that)
        (S
          (PP (IN in) (DT the) (NN presence) (IN of)
            (NP
              (NP
                (NP (DT the) (JJS highest) (NN concentration))
                (PP (IN of)
                  (NP
                    (NP (NN SEB))
                    (VP (VBN tested)))))
              (PRN (-LRB- -LRB-)
                (NP (CD 10) (NN μg/ml))
                (-RRB- -RRB-))))
          (, ,)
          (NP (NN WT) (NN T) (NNS cells))
          (VP (VBD responded)
            (ADVP (RBR more) (RB robustly))
            (PP (IN than)
              (NP (NN ITK) (NN null) (NN T) (NNS cells)))
            (PRN (-LRB- -LRB-)
              (S
                (VP (VB see)
                  (NP (NNP Fig.) (CD 1c))))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Indeed))
      (, ,)
      (PP (IN at)
        (NP
          (NP (PDT all) (DT the) (NNS doses))
          (VP (VBN tested))))
      (, ,)
      (NP (PRP$ our) (NN analysis))
      (VP (VBD indicated)
        (SBAR (IN that)
          (S
            (NP (NN ITK) (NN null) (NN T) (NNS cells))
            (VP (VBD responded)
              (ADJP (RBR less)
                (PP (IN than)
                  (NP (JJ WT) (NN T) (NNS cells))))
              (PP (IN on)
                (NP
                  (NP (NN day)
                    (QP (CD 3) (, ,) (CD 4)
                      (CC and)
                      (CD 5)))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Fig.) (CD 1d–f))
                    (-RRB- -RRB-))))
              (, ,)
              (SBAR (IN while)
                (S
                  (NP (NN proliferation))
                  (VP (VBD was)
                    (ADJP (JJ equivalent))
                    (SBAR
                      (WHADVP (WRB when))
                      (S
                        (NP
                          (NP (NN PMA))
                          (CC and)
                          (NP (NN Ionomycin)))
                        (VP (VBD was)
                          (VP (VBN used)
                            (S
                              (VP (TO to)
                                (VP (VB bypass)
                                  (NP (NN TcR) (NNS signals))
                                  (PRN (-LRB- -LRB-)
                                    (S
                                      (NP (NNS data))
                                      (VP (RB not) (VBN shown)))
                                    (-RRB- -RRB-)))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS data))
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (NP (NN ITK) (NN null) (NN T) (NNS cells))
            (VP (VBP have)
              (NP
                (NP
                  (ADJP (RB significantly) (VBN reduced))
                  (JJ proliferative) (NNS responses))
                (PP (TO to)
                  (NP (NN SEB))))
              (ADVP (FW in) (FW vitro)))))))
    (. .)))

(
  (S
    (S
      (NP (NN Interleukin-2))
      (VP (VBZ is)
        (NP
          (NP (CD one))
          (PP (IN of)
            (NP
              (NP (DT the) (NNS cytokines))
              (VP (VBN induced)
                (PP (IN by)
                  (NP
                    (NP (NN exposure))
                    (PP (TO to)
                      (NP (NN SEB) (CD -LSB-22))))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (NN ITK))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB regulate)
                  (NP (NN IL-2) (NN secretion))
                  (ADVP (FW in) (FW vitro))
                  (PP
                    (PP (IN by)
                      (NP
                        (NP (NN T) (NNS cells))
                        (VP (VBN stimulated) (NN anti-CD3/TcR) (NNS antibodies))))
                    (CC or)
                    (PP (IN in)
                      (NP
                        (NP (NN response))
                        (PP (TO to)
                          (NP (NN peptide) (NN antigen) (NN -LSB-15,18,23,24)))))
                    (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB therefore))
      (VP (VBD determined)
        (NP
          (NP (DT the) (NNS levels))
          (PP (IN of)
            (NP (NN IL-2)))
          (PP (IN in)
            (NP
              (NP (NNS supernatants))
              (PP (IN from)
                (NP
                  (NP (NNS cells))
                  (VP
                    (ADVP (RB similarly))
                    (VBN stimulated)
                    (PP (IN with)
                      (NP (NN SEB)))))))))
        (ADVP (FW in) (FW vitro))
        (-LRB- -LRB-)
        (NP (NNP Fig.) (CD 2))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (SBAR (IN While)
        (S
          (NP (NN WT) (NN T) (NNS cells))
          (VP (VBD responded)
            (PP (TO to)
              (NP (NN SEB)))
            (PP (IN by)
              (NP
                (NP (NN secretion))
                (PP (IN of)
                  (NP (NN IL-2)))
                (PP (IN within)
                  (NP
                    (NP (CD 24) (NN hrs.))
                    (PP (IN of)
                      (NP
                        (NP (NN stimulation))
                        (PP (IN in)
                          (NP
                            (NP (DT a) (NN dose) (JJ dependent) (NN manner))
                            (PRN (-LRB- -LRB-)
                              (S
                                (VP (VB see)
                                  (NP
                                    (NP
                                      (NP (NNP Fig.))
                                      (NP (NN 2a)))
                                    (PP (IN for)
                                      (NP
                                        (ADJP (CD 5) (NN μg/ml))
                                        (NN dose))))))
                              (-RRB- -RRB-))))))))))
            (, ,)
            (S
              (VP (VBG starting)
                (PP (IN at)
                  (NP
                    (NP (DT the)
                      (ADJP (CD 0.5) (NN μg/ml))
                      (NN SEB) (NN concentration))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Fig.) (NNP 2bi))
                      (-RRB- -RRB-)))))))))
      (, ,)
      (NP (NN ITK) (NN null) (NN T) (NNS cells))
      (VP (VBD made)
        (NP
          (ADJP (RB very) (JJ little))
          (NN IL-2))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (JJ small) (NN amount))
        (PP (IN of)
          (NP (NN IL-2)))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBD was)
              (VP (VBN made))))))
      (VP (VBD was)
        (ADVP (RB only))
        (PP (IN at)
          (NP
            (NP (DT the) (JJS highest) (NN concentration))
            (PP (IN of)
              (NP (NN SEB)))
            (VP (VBN tested))))
        (PRN (-LRB- -LRB-)
          (NP (CD 5) (NN μg/ml))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP (NN ITK) (NN null) (NN T) (NNS cells))
      (ADVP (RB consistently))
      (VP (VBN secreted)
        (NP (RBR less) (NN IL-2))
        (PP (IN over)
          (NP
            (NP (DT the)
              (NP (JJ 5-day) (NN period))
              (CC and)
              (NP (NN dose) (NN range)))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (NN 2b))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS data))
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (SBAR (IN as)
              (S
                (ADVP (RB previously))
                (VP (VBN reported)
                  (PP (IN for)
                    (NP
                      (NP (NN TcR))
                      (CC or)
                      (NP (JJ antigenic) (NN stimulation)))))))
            (, ,)
            (NP (NN ITK))
            (VP (VBZ regulates)
              (NP
                (NP (DT the) (NN production))
                (PP (IN of)
                  (NP (NN IL-2))))
              (ADVP (FW in) (FW vitro))
              (PP (IN in)
                (NP
                  (NP (NN response))
                  (PP (TO to)
                    (NP (NN SEB) (NN stimulation) (CD -LSB-15,18,23,24))))))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (SBAR (IN While)
      (S
        (NP (DT these) (NNS data))
        (VP (VBP indicate)
          (SBAR (IN that)
            (S
              (NP (NN ITK))
              (VP (VBZ regulates)
                (NP (NN T) (NN cell) (NN proliferation))
                (PP (IN in) (NN response) (TO to)
                  (NP (NN SEB)))
                (ADVP (FW in) (FW vitro))))))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (ADJP (JJ possible))
      (SBAR (IN that)
        (S
          (PP (IN within)
            (NP
              (NP (DT the) (NN context))
              (PP (IN of)
                (NP
                  (NP (NN antigen) (NN presentation))
                  (CC and)
                  (NP (JJ optimal) (JJ co-stimulatory) (NNS signals))))
              (ADVP (FW in) (FW vivo))))
          (, ,)
          (NP (NN ITK) (NN null) (NN T) (NNS cells))
          (VP (MD may)
            (VP (VB exhibit)
              (NP (DT a) (JJR better) (NN response)))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Exposure))
      (PP (IN of)
        (NP (NNS animals)))
      (PP (TO to)
        (NP (NN SEB))))
    (VP (VBZ results)
      (PP (IN in)
        (NP
          (NP (DT an) (NN expansion))
          (PP (IN of)
            (NP (DT the) (NN SEB) (JJ reactive) (NN T) (NN cell) (NN population)))
          (PP (IN with)
            (NP
              (NP (DT a) (NN peak))
              (PP (IN of)
                (NP
                  (NP
                    (QP (IN around) (CD 2))
                    (NNS days))
                  (PP (IN post)
                    (NP (NN exposure) (CD -LSB-2,4))))))))))
    (-RRB- -RSB-) (. .)))

(
  (S
    (SBAR (IN In) (NN order) (TO to)
      (S
        (VP (VB determine)
          (SBAR (IN if)
            (S
              (NP
                (NP (DT the) (VBN reduced) (JJ proliferative) (NNS responses))
                (VP (VBN seen)
                  (PP (IN with)
                    (NP (DT the) (NN ITK) (NN null) (NN T) (NNS cells)))
                  (ADVP (FW in) (FW vitro))))
              (VP (VBD was)
                (ADVP (RB also))
                (VP (VBN seen)
                  (PP (IN in)
                    (NP (FW vivo))))))))))
    (, ,)
    (NP (PRP we))
    (VP
      (VP (VBD exposed)
        (NP (NN WT)
          (CC and)
          (NN ITK) (NN null) (NNS animals))
        (PP (TO to)
          (NP (NN SEB))))
      (CC and)
      (VP (VBD determined)
        (NP
          (NP (DT the) (NNS percentages))
          (PP (IN of)
            (NP
              (NP (NNP Vβ8))
              (CC and)
              (NP (NNP Vβ6))
              (NP (JJ positive) (NNS cells))))
          (PP (IN in)
            (NP (DT the) (JJ CD4+) (NN population))))
        (PP (IN by)
          (NP
            (NP (NN flow) (NN cytometry))
            (PP (IN after)
              (NP
                (NP
                  (QP (CD 2) (, ,) (CD 4)
                    (CC and)
                    (CD 5))
                  (NNS days))
                (PP (IN as)
                  (NP
                    (NP (DT a) (NN measure))
                    (PP (IN of)
                      (NP (NN T) (NN cell) (NN expansion)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (NN T) (NNS cells))
          (VP (VBG bearing)
            (NP (NN Vβ8) (NN TcR) (NNS chains))))
        (VP (VBP are)
          (ADJP (JJ responsive)
            (PP (TO to)
              (NP (NN SEB) (NN stimulation))))
          (SBAR (IN while)
            (S
              (NP
                (NP (DT those))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (VB bear)
                      (NP (NN Vβ6) (NN TcR) (NNS chains))))))
              (VP (VBP are) (RB not))))))
      (, ,) (IN so)
      (S
        (NP (PRP we))
        (VP (VBD analyzed)
          (NP
            (NP (DT these) (CD two) (NNS populations))
            (PP (IN of)
              (NP (NN T) (NNS cells)))))))
    (. .)))

(
  (S
    (SBAR (IN As)
      (S
        (ADVP (RB previously))
        (VP (VBN reported))))
    (, ,)
    (PP (IN in)
      (NP (JJ WT) (NNS animals)))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT an)
          (ADJP
            (QP (RB approximately) (CD 4))
            (JJ fold))
          (NN expansion))
        (PP (IN in)
          (NP (NN Vβ8) (JJ CD4+) (NN T) (NNS cells))))
      (PP (IN in)
        (NP
          (NP (NN spleen))
          (CC and)
          (NP (NN lymph) (NNS nodes))))
      (PP (VBG following)
        (NP
          (NP (NN SEB) (NN exposure))
          (PRN (-LRB- -LRB-)
            (ADVP (RB as))
            (VP (VBN compared)
              (PP (TO to)
                (NP
                  (NP (NN exposure))
                  (PP (TO to)
                    (NP
                      (NP (NN PBS))
                      (, ,)
                      (NP (NN fig) (NN 3a))
                      (, ,)
                      (NP (NN b)))))))
            (-RRB- -RRB-))))
      (, ,)
      (SBAR (IN while)
        (S
          (NP (JJ Vβ6) (JJ CD4+) (NN T) (NN cell) (NNS populations))
          (VP (VBD were)
            (ADJP (RB largely) (JJ unchanged))
            (PRN (-LRB- -LRB-)
              (S
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (PP (IN By)
      (NP (NN contrast)))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP
          (ADJP (RB statistically) (RB significantly) (JJR less))
          (NN expansion))
        (PP (IN of)
          (NP (NN ITK) (NN null) (NN Vβ8+CD4+) (NN T) (NNS cells))))
      (PP (VBG following)
        (NP (NN SEB) (NN exposure)))
      (, ,)
      (SBAR (IN although)
        (S
          (NP
            (NP (DT these) (NNS cells))
            (VP
              (ADVP (RB still))
              (VBN expanded)))
          (PRN (-LRB- -LRB-)
            (NP
              (NP
                (NP (NNP Fig.))
                (NP (NN 3a)))
              (, ,)
              (NP (NN b)))
            (-RRB- -RRB-))
          (SBAR (IN As)
            (S
              (ADVP (RB previously))
              (VP (VBN reported))))
          (, ,)
          (NP
            (NP (DT the) (NNS percentages))
            (PP (IN of)
              (NP
                (NP (NN T) (NNS cells))
                (VP (VBG bearing)
                  (NP (NN Vβ6))))))
          (VP (VBD did) (RB not)
            (VP (VB change)
              (PP (IN over)
                (NP
                  (NP (DT this) (NN period))
                  (PP (IN in)
                    (NP
                      (NP
                        (NP (CC either)
                          (NP (DT the) (NN WT))
                          (CC or)
                          (NP (NN ITK)))
                        (JJ null) (NNS mice))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP
                            (NP (NNS data))
                            (VP (RB not) (VBN shown)))
                          (CC and)
                          (NP (NN -LSB-4)))
                        (-RRB- -RSB-) (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (NP
        (NP (DT the) (NN absence))
        (PP (IN of)
          (NP (NN ITK))))
      (VP (VBZ results)
        (PP (IN in)
          (NP (VBN reduced) (NN T) (NN cell) (NN expansion)))
        (ADVP (FW in) (FW vivo))
        (PP (IN in) (NN response) (TO to)
          (NP (NN SEB)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN T) (NNS cells))
        (PP (IN from)
          (NP (NN ITK) (JJ null) (NNS mice))))
      (VP
        (VP (VBP proliferate)
          (NP (JJR less))
          (ADVP
            (ADVP (FW in) (FW vitro))
            (CC and)
            (ADVP (FW in) (FW vivo))))
        (, ,)
        (CC and)
        (VP (VB secrete)
          (NP
            (ADJP (RB significantly) (JJR less))
            (NN IL-2))
          (ADVP (FW in) (FW vitro))
          (PP (IN in) (NN response) (TO to)
            (NP (NN SEB))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB therefore))
      (VP (VBD determined)
        (SBAR (IN if)
          (S
            (NP (PRP they))
            (VP (MD would)
              (ADVP (RB also))
              (VP (VB secrete)
                (NP (RBR less) (NN IL-2))
                (PP (VBG following)
                  (NP (NN SEB) (NN stimulation)))
                (ADVP (FW in) (FW vivo))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (NNS Groups))
          (PP (IN of)
            (NP (NNS mice))))
        (VP (VBD were)
          (VP (VBN exposed)
            (PP (TO to)
              (NP (NN SEB)))
            (ADVP (RB i.v.)))))
      (CC and)
      (S
        (PP (IN at)
          (NP (JJ various) (NN time) (NNS points)))
        (NP (PRP$ their) (NN serum))
        (VP (VBD was)
          (VP
            (VP (VBN taken))
            (CC and)
            (VP (VBN analyzed)
              (PP (IN for)
                (NP (NN IL-2) (NN production))))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (PP (IN in)
            (NP
              (NP (NN comparison))
              (PP (TO to)
                (NP
                  (ADJP (FW in) (FW vitro))
                  (NN IL-2) (NN production)))))
          (, ,)
          (SBAR
            (WHADVP (WRB when))
            (S
              (NP (NN WT) (NNS mice))
              (VP (VBD were)
                (VP (VBN exposed)
                  (PP (TO to)
                    (NP (NN SEB)))
                  (ADVP (FW in) (FW vivo))))))
          (NP (PRP they))
          (VP (VBD produced)
            (NP (NN IL-2))
            (PP (IN within)
              (NP
                (NP (CD 1) (NN hr.))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (VBD peaked)
                      (PP (IN at)
                        (PP (IN around)
                          (NP (CD 2) (NNS hrs)))))))))))))
    (. .)))

(
  (S
    (S
      (PRN (-LRB- -LRB-)
        (NP (NNP Fig.) (CD 4))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (S
      (ADJP (JJ consistent)
        (PP (IN with)
          (NP (DT the)
            (ADJP (FW in) (FW vitro))
            (NN stimulation)))))
    (, ,)
    (NP (NN ITK) (JJ deficient) (NNS mice))
    (VP (VB secrete)
      (NP
        (NP
          (ADJP (RB significantly) (JJR less))
          (NN IL-2))
        (PP (IN in)
          (NP
            (NP (NN response))
            (PP (TO to)
              (NP (NN SEB))))))
      (ADVP (FW in) (FW vivo))
      (-LRB- -LRB-)
      (NP (NNP Fig.) (CD 4))
      (-RRB- -RRB-))
    (. .)))

(
  (S
    (PP (VBN Based)
      (PP (IN on)
        (NP (DT these) (NNS data))))
    (NP (PRP we))
    (VP (VBP conclude)
      (SBAR
        (SBAR (IN that)
          (S
            (NP
              (ADJP (FW in) (FW vivo))
              (NN IL-2) (NN production))
            (VP (VBZ occurs)
              (ADJP
                (ADJP (JJR earlier))
                (SBAR (IN than)
                  (S
                    (VP (VBN observed)
                      (ADVP (FW in) (FW vitro)))))))))
        (, ,)
        (CC and)
        (SBAR (IN that)
          (S
            (NP (NN ITK) (NN null) (NN T) (NNS cells))
            (VP (VBP continue)
              (S
                (VP (TO to)
                  (VP (VBP exhibit)
                    (NP
                      (NP (NNS defects))
                      (PP (IN in)
                        (NP
                          (NP (NN IL-2) (NN production))
                          (PP (IN in)
                            (NP
                              (NP (NN response))
                              (PP (TO to)
                                (NP (NN SEB))))))))
                    (ADVP (FW in) (FW vivo))
                    (, ,)
                    (PP
                      (ADVP (RB even))
                      (IN in)
                      (NP
                        (NP (DT the) (JJ presumed) (NN presence))
                        (PP (IN of)
                          (NP (JJ adequate) (JJ costimulatory) (NNS signals)))
                        (ADVP (FW in) (FW vivo))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN JNK) (NN MAPK) (NN pathway))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB be)
                  (ADJP (JJ essential)
                    (PP (IN for)
                      (NP
                        (NP (NN IL-2) (NN production))
                        (PP (IN upon)
                          (NP
                            (NP (NN stimulation))
                            (PP (IN of)
                              (NP (NN T) (NNS cells)))
                            (PP (IN by)
                              (NP (DT the)
                                (NP (NN TcR))
                                (CC and)
                                (NP (NN CD28))
                                (NP
                                  (ADJP (FW in) (FW vitro))
                                  (NN -LSB-25-28))))
                            (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN pathway))
      (VP (VBZ leads)
        (PP (TO to)
          (NP
            (NP
              (NP (NN phosphorylation))
              (PP (IN of)
                (NP (NN c-jun))))
            (CC and)
            (NP
              (NP (NN activation))
              (PP (IN of)
                (NP
                  (NP (DT an) (NN AP-1) (NN transcription) (NN factor) (NN complex))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBZ is)
                        (VP (VBN required)
                          (PP (IN for)
                            (NP (NN IL-2) (NN transcription) (CD -LSB-28) (-RRB- -RSB-))))))))))))))
    (. .)))

(
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP (NN activation))
          (PP (IN of)
            (NP
              (NP (DT the) (NN JNK) (NN pathway))
              (VP (VBG leading)
                (PP (TO to)
                  (NP
                    (NP
                      (NP (NN phosphorylation))
                      (CC and)
                      (NP (NN activation)))
                    (PP (IN of)
                      (NP (NN c-jun)))))))))
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN demonstrated)
              (PP (IN in)
                (NP (NN T) (NNS cells)))
              (PP
                (PP (VBG following)
                  (NP
                    (NP
                      (NP
                        (NP (NN TcR))
                        (CC and)
                        (NP (NN CD28)))
                      (NN crosslinking))
                    (ADVP (FW in) (FW vitro))))
                (, ,)
                (CONJP (RB as) (RB well) (IN as))
                (PP (IN by)
                  (NP (NN peptide) (NN antigen) (NN stimulation))))
              (ADVP (FW in) (FW vivo)))))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is) (RB not)
      (VP (VB clear)
        (SBAR (IN whether)
          (S
            (NP (DT the) (NN SAG) (NN SEB))
            (VP (VBZ activates)
              (NP (DT this) (NN pathway))
              (PP (IN in)
                (NP (FW vivo) (NN -LSB-29,30) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB therefore))
      (VP (VBD tested)
        (SBAR (IN whether)
          (S
            (NP (NN SEB))
            (VP (MD could)
              (VP (VB induce)
                (NP
                  (NP (NN phosphorylation))
                  (PP (IN of)
                    (NP (NN c-jun))))
                (PP (IN in)
                  (NP
                    (NP (JJ WT) (NN T) (NNS cells))
                    (VP (VBN stimulated)
                      (PP (IN with)
                        (NP (NN SEB)))
                      (ADVP (FW in) (FW vivo)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VBP do)
            (NP (DT this)))))
      (, ,)
      (NP (PRP we))
      (VP (VBN adapted)
        (NP
          (NP (DT a) (NN method))
          (VP
            (ADVP (RB initially))
            (VBN used)
            (PP (IN by)
              (NP
                (NP (NNP Jenkins))
                (CC and)
                (NP (NNS colleagues))))))
        (S
          (VP (TO to)
            (VP (VB analyze)
              (NP
                (NP (NN phosphorylation))
                (PP (IN of)
                  (NP (NN c-jun))))
              (PP (VBG following)
                (NP
                  (NP
                    (ADJP (FW in) (FW vivo))
                    (NN exposure))
                  (PP (IN of)
                    (NP (NN antigen))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT this) (NN protocol)))
      (, ,)
      (NP (NNS mice))
      (VP (VBD were)
        (VP (VBN exposed)
          (PP (TO to)
            (NP (NN SEB)))
          (, ,)
          (ADVP (RB then))
          (NP
            (NP (NNS cells))
            (PP (IN from)
              (NP
                (NP (NN lymph) (NNS nodes))
                (, ,)
                (NP
                  (NP
                    (NP (NN spleen))
                    (CC and)
                    (NP (NN blood)))
                  (ADJP
                    (ADJP (RB rapidly) (VBN isolated))
                    (CC and)
                    (ADJP (JJ fixed))))
                (, ,)
                (CC and)
                (NP
                  (NP (NNS antibodies))
                  (ADJP (JJ specific)
                    (PP (IN for)
                      (NP
                        (NP (VBN phosphorylated) (NN c-jun))
                        (VP (VBN used)
                          (S
                            (VP (TO to)
                              (VP (VB analyze)
                                (NP (PRP$ its) (NN phosphorylation))))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP (NNS cells))
      (VP (VBD were)
        (VP (VBN stained)
          (PP (IN with)
            (NP
              (NP (NNS antibodies))
              (ADJP (JJ specific)
                (PP (TO to)
                  (NP
                    (NP (NNP Vβ8))
                    (CC or)
                    (NP (NNP Vβ6)))))))
          (S
            (VP (TO to)
              (VP (VB detect)
                (NP
                  (ADJP
                    (ADJP (NN SEB) (JJ responsive))
                    (CC and)
                    (ADJP (JJ non-responsive)))
                  (NN T) (NNS cells))
                (ADVP (RB respectively))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Flow) (NN cytometry))
      (VP (VBD was)
        (VP (VBN employed)
          (S
            (VP (TO to)
              (VP (VB detect)
                (NP
                  (NP (NN phosphorylation))
                  (PP (IN of)
                    (NP (NN c-jun) (CD -LSB-30))))))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 5))
      (VP (VBZ demonstrates)
        (PP (IN that)
          (NP (CD 1) (NN hr)))))
    (. .)))

(
  (S
    (S
      (PP (IN after)
        (NP
          (NP (JJ intravenous) (NN exposure))
          (PP (TO to)
            (NP (NN SEB)))))
      (, ,)
      (NP
        (NP (JJ Vβ8+) (NN SEB) (JJ reactive) (NN T) (NNS cells))
        (PP (IN in)
          (NP
            (NP (NN spleen))
            (CC and)
            (NP (NN lymph) (NNS nodes)))))
      (VP (VBP contain)
        (NP
          (NP (JJR higher) (NNS levels))
          (PP (IN of)
            (NP
              (NP (VBN phosphorylated) (NN c-jun))
              (PRN (-LRB- -LRB-)
                (NP (NN cf))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Figs))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NN 5a))
        (, ,)
        (NP (NN b) (CD iii)))
      (NP (NNP &) (CD iv) (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (NP (JJ Similar) (NNS results))
      (VP (VBD were)
        (VP (VBN found)
          (PP (IN in)
            (NP
              (NP (NNS animals))
              (VP (VBN exposed)
                (PP (TO to)
                  (NP (NN SEB)))
                (ADVP
                  (ADVP (RB i.p.))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNS data))
                      (VP (RB not) (VBN shown)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN By)
        (NP (NN contrast)))
      (, ,)
      (NP
        (NP
          (NP (NN T) (NNS cells))
          (ADJP (JJ non-reactive)
            (PP (TO to)
              (NP
                (NP (NN SEB))
                (PP (IN in)
                  (NP (DT the) (JJ same) (NNS animals)))))))
        (, ,)
        (NP
          (NP (DT those))
          (VP (VBG bearing)
            (NP (JJ Vβ6+) (NNS TcRs))))
        (, ,))
      (VP (VBD did) (RB not)
        (VP (VB have)
          (NP
            (NP (DT any) (NN increase))
            (PP (IN in)
              (NP
                (NP (VBN phosphorylated) (NN c-jun))
                (PRN (-LRB- -LRB-)
                  (NP (NN cf)))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Figs))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NN 5a))
        (, ,)
        (NP (NN b))
        (, ,))
      (NP (NN i) (NN &) (CD ii) (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ demonstrates)
        (SBAR (IN that)
          (S
            (PP (IN in)
              (NP (DT the) (JJ same) (NN animal)))
            (, ,)
            (ADVP (RB only))
            (NP
              (NP (DT those) (NN T) (NNS cells))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP
                    (VP (VBP interact)
                      (PP (IN with)))
                    (CC and)
                    (VP (MD can)
                      (VP (VB be)
                        (VP (VBN activated)
                          (PP (IN by)
                            (NP (NN SEB))))))))))
            (VP (VBP respond)
              (PP (IN by)
                (NP
                  (NP (NN phosphorylation))
                  (PP (IN of)
                    (NP (NN c-jun)))))
              (, ,)
              (SBAR (IN while)
                (S
                  (PP (IN at)
                    (NP (DT the) (JJ same) (NN time)))
                  (, ,)
                  (NP
                    (NP (DT those) (NN T) (NNS cells))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBP are) (RB not)
                          (ADJP (JJ reactive))))))
                  (VP (VBP are) (RB not)
                    (VP (VBN activated) (, ,)
                      (S
                        (VP (VBG demonstrating)
                          (NP (NN specificity)))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Similarly))
      (, ,)
      (NP
        (NP (NNS animals))
        (VP (VBN injected)
          (PP (IN with)
            (NP (NNS PBS)))))
      (VP (VBD showed)
        (NP
          (NP (DT no) (JJ such) (NN change))
          (PP (IN in)
            (NP (VBN phosphorylated) (NN c-jun)))
          (PP (IN in)
            (NP (CC either)
              (DT the)
              (ADJP
                (ADJP (NN SEB) (JJ reactive))
                (CC or)
                (ADJP (JJ non-reactive)))
              (NN T) (NN cell) (NNS populations))))
        (, ,)
        (S
          (VP (VBG indicating)
            (SBAR (IN that)
              (S
                (NP (DT this))
                (VP (VBD was)
                  (NP
                    (NP (DT an)
                      (ADJP (NN SEB) (JJ mediated))
                      (NN event))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Fig.) (CD 5a–b))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Other) (NNS controls))
        (PP (VBG including)
          (NP (JJ secondary) (NNS reagents))))
      (ADVP (RB alone))
      (VP (VBP demonstrate)
        (NP
          (NP (DT the) (NN specificity))
          (PP (IN of)
            (NP (NN antibody) (NN staining))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (NNS data))
            (VP (RB not) (VBN shown)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB next))
      (VP (VBD determined)
        (SBAR (IN whether)
          (S
            (NP
              (NP (NN T) (NNS cells))
              (VP (VBG lacking)
                (NP (NN ITK))))
            (VP (MD could)
              (VP (VB induce)
                (NP (NN c-jun) (NN phosphorylation))
                (PP (IN in) (NN response) (TO to)
                  (NP (NN SEB) (NN activation)))
                (ADVP (FW in) (FW vivo))))))))
    (. .)))

(
  (S
    (S
      (NP (NN ITK) (JJ null) (NNS mice))
      (VP (VBD were)
        (VP (VBN exposed)
          (PP (TO to)
            (NP (NN SEB)))
          (SBAR (IN as)
            (S
              (VP (VBN described)
                (ADVP (RB above))))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (NN phosphorylation))
        (PP (IN of)
          (NP (NN c-jun))))
      (VP (VBN determined)
        (PP (IN in)
          (NP
            (NP
              (NP
                (NP (JJ Vβ8+) (NN T) (NN cell) (NN population))
                (PRN (-LRB- -LRB-)
                  (NP (NN SEB) (JJ reactive))
                  (-RRB- -RRB-)))
              (CC or)
              (NP
                (NP (JJ Vβ6+) (NN T) (NN cell) (NN population))
                (PRN (-LRB- -LRB-)
                  (NP (JJ non-reactive))
                  (-RRB- -RRB-))))
            (PP (IN in)
              (NP (DT the) (JJ same) (NNS animals)))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS experiments))
      (VP (VBP show)
        (SBAR (IN that)
          (S
            (PP (IN in)
              (NP
                (NP (DT the) (NN absence))
                (PP (IN of)
                  (NP (NN ITK)))))
            (, ,)
            (NP (NN SEB))
            (VP (VBZ does) (RB not)
              (VP (VB lead)
                (PP (TO to)
                  (NP
                    (NP (NN phosphorylation))
                    (PP (IN of)
                      (NP (NN c-jun)))
                    (PP (IN in)
                      (NP (DT either) (NN T) (NN cell) (NN population)))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (CD 6a–d))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP
        (NP (DT the) (NN absence))
        (PP (IN of)
          (NP (NN ITK))))
      (VP (VBZ results)
        (PP (IN in)
          (NP
            (NP (DT the) (NN lack))
            (PP (IN of)
              (NP
                (NP (NN SEB) (NN phosphorylation))
                (PP (IN of)
                  (NP (NN c-jun)))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (MD could)
                      (VP (VB affect)
                        (NP
                          (NP (DT the) (NN ability))
                          (PP (IN of)
                            (NP (DT these) (NN T) (NNS cells)))
                          (S
                            (VP (TO to)
                              (VP (VB produce)
                                (NP (NN IL-2))))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB determine)
            (SBAR (IN if)
              (S
                (NP
                  (NP (DT this) (NN lack))
                  (PP (IN of)
                    (NP (NN c-jun) (NN phosphorylation)))
                  (PP (IN in)
                    (NP
                      (NP (NN ITK) (NN null) (NN T) (NNS cells))
                      (PP (IN in)
                        (NP
                          (NP (NN response))
                          (PP (TO to)
                            (NP (NN SEB))))))))
                (VP (VBD reflected)
                  (NP
                    (NP (JJ global) (NN nonresponsiveness))
                    (PP (IN in)
                      (NP (DT these) (NNS cells))))))))))
      (, ,)
      (S
        (NP (PRP we))
        (VP (VBD determined)
          (SBAR (IN whether)
            (S
              (NP (DT these) (NNS cells))
              (VP (VBD were)
                (ADVP (RB indeed))
                (VP (VBN activated)
                  (PP (IN by)
                    (NP (NN SEB) (NN exposure))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VBP do)
            (NP (DT this)))))
      (, ,)
      (NP (PRP we))
      (VP (VBD measured)
        (NP
          (NP (NNS increases))
          (PP (IN in)
            (NP
              (NP (NN CD69) (NN expression))
              (, ,)
              (NP
                (NP (DT a) (NN cell) (NN surface) (NN protein))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (VBZ is)
                      (ADVP (RB rapidly))
                      (VP (VBN expressed)
                        (PP (IN by)
                          (NP (VBN activated) (NN T) (NNS cells)))
                        (PP (IN in)
                          (NP (DT a)
                            (ADJP (NN Ras/MAPK) (JJ dependent))
                            (NN manner) (CD -LSB-31-33) (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Similar) (NNS experiments))
      (VP (VBD were)
        (VP (VBN performed)
          (PP (IN as)
            (NP
              (NP (DT those))
              (VP (VBG examining)
                (NP (NN c-jun) (NN phosphorylation))))))
        (, ,)
        (SBAR
          (WHPP (IN except)
            (WHNP (WDT that)))
          (S
            (NP (PRP we))
            (VP (VBD used)
              (NP
                (NP (JJ specific) (NNS antibodies))
                (PP (IN against)
                  (NP (NN CD69))))
              (S
                (VP (TO to)
                  (VP (VB determine)
                    (SBAR (IN if)
                      (S
                        (NP (DT the) (NN SEB) (JJ reactive) (NNS cells))
                        (VP (VBD had)
                          (VP (VBN been)
                            (VP (VBN activated))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 7))
      (VP (VBZ demonstrates)
        (SBAR (IN that)
          (S
            (NP
              (NP
                (NP (JJ Vβ8+CD4+) (NN T) (NNS cells))
                (CONJP (CC but)
                  (RB not))
                (NP (NN Vβ6+CD4+) (NN T) (NNS cells)))
              (PP (IN from)
                (NP (DT both) (NN WT)
                  (CC and)
                  (NN ITK) (JJ null) (NNS mice))))
            (VP (VBD exhibited)
              (NP
                (NP (NNS increases))
                (PP (IN in)
                  (NP (NN CD69) (NN expression) (CD 2) (NNS hours))))
              (PP (VBG following)
                (NP (NN SEB) (NN exposure)))
              (, ,)
              (S
                (VP (VBG indicating)
                  (SBAR (IN that)
                    (S
                      (PP (IN in)
                        (NP (DT both) (NNS cases)))
                      (, ,)
                      (NP (DT the) (NN T) (NNS cells))
                      (VP (VBD were)
                        (VP (VBG responding)
                          (PP (TO to)
                            (NP
                              (NP (NN SEB) (NN activation))
                              (PRN (-LRB- -LRB-)
                                (NP (NNP Fig.) (CD 7))
                                (-RRB- -RRB-)))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (NN SEB))
      (VP (VBD induced)
        (NP
          (NP (NN CD69) (NN expression))
          (PP (IN on)
            (NP
              (NP (DT a) (JJR higher) (NN percentage))
              (PP (IN of)
                (NP (JJ Vβ8+CD4+) (NN SEB) (VBG responding) (NN T) (NNS cells)))))
          (PP (IN in)
            (NP (JJ WT) (NNS mice))))
        (PP (IN than)
          (PP (IN in)
            (NP
              (NP (NN ITK) (JJ null) (NNS mice))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP
                    (NP
                      (QP (CD 73.5)
                        (CC +/-)
                        (CD 12))
                      (NN %))
                    (PP (IN in)
                      (NP (NN WT))))
                  (CC vs.)
                  (NP
                    (NP
                      (QP (CD 43.6)
                        (CC +/-)
                        (CD 0.5))
                      (NN %))
                    (PP (IN in)
                      (NP (NN ITK) (NN null)))))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (NN difference))
        (PP (IN in)
          (NP
            (NP (DT the) (NN MFI))
            (PP (IN of)
              (NP
                (NP (NN CD69) (NN expression) (NN WT) (VBG responding) (NN T) (NNS cells))
                (CC vs.)
                (NP (NN ITK) (NN null) (VBG responding) (NN T) (NNS cells)))))))
      (PRN (-LRB- -LRB-)
        (NP
          (NP
            (NP (CD 362.5) (JJ _+/-)
              (NP (CD 6.3)))
            (PP (IN in)
              (NP (NN WT))))
          (CC vs.)
          (NP
            (NP (CD 375)
              (CC +/-)
              (CD 11.3))
            (PP (IN in)
              (NP (NN ITK) (NN null)))))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP (EX there))
      (VP (VBD was)
        (NP
          (NP (DT no) (NN difference))
          (PP (IN in)
            (NP
              (NP (DT the) (NN expression))
              (PP (IN of)
                (NP (NN CD25)))
              (PP (IN on)
                (NP
                  (NP
                    (NP (NN WT))
                    (CC or)
                    (NP (NN ITK)))
                  (NN null) (NN T) (NNS cells))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (NNS data))
            (VP (RB not) (VBN shown)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (ADVP (RB Thus))
    (NP
      (NP (DT the) (NN lack))
      (PP (IN of)
        (NP
          (ADJP (NN SEB) (JJ induced))
          (NN c-jun) (NN phosphorylation)))
      (PP (IN in)
        (NP (NN ITK) (NN null) (NN T) (NNS cells))))
    (VP (VBZ seems)
      (S
        (VP (TO to)
          (VP (VB reflect)
            (NP
              (NP (DT the) (JJ specific) (NN role))
              (PP (IN of)
                (NP (NN ITK)))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP
                      (NP (DT this) (NN event))
                      (PP (IN in)
                        (NP
                          (NP (NN response))
                          (PP (TO to)
                            (NP (NN SEB) (NN exposure))))))
                    (ADVP (FW in) (FW vivo))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Exposure))
        (PP (IN of)
          (NP (NNS mice)))
        (PP (TO to)
          (NP
            (NP (NN SEB))
            (CC and)
            (NP (NN LPS)))))
      (VP (VBZ results)
        (PP (IN in)
          (NP
            (NP (NN toxicity))
            (VP (VBG culminating)
              (PP (IN in)
                (NP (NN death) (NN -LSB-1) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB therefore))
      (VP (VBD analyzed)
        (NP
          (NP (DT the) (NN effect))
          (PP (IN of)
            (NP
              (NP (NN exposure))
              (PP (TO to)
                (NP (NN SEB/LPS)))))
          (PP (IN on)
            (NP (NN ITK) (JJ null) (NNS mice))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (PP (IN in) (NN contrast) (TO to)
        (NP
          (NP (DT the) (NNS results))
          (PP (IN with)
            (NP
              (NP (NN IL-2) (NN secretion))
              (CC and)
              (NP (NN T) (NN cell) (NN expansion))))))
      (, ,)
      (NP (DT both) (NNS mice))
      (VP (VBD were)
        (VP (VBN affected)
          (ADVP (RB similarly))
          (PRN (-LRB- -LRB-)
            (NP (NN Table) (CD 1))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (RB Thus) (DT the) (JJ same) (NN proportion))
        (PP (IN of)
          (NP (NNS mice))))
      (VP (VBD became)
        (ADJP (JJ sick))
        (PP (VBG following)
          (NP
            (NP
              (NP (NN exposure))
              (PP (TO to)
                (NP (NN SEB))))
            (CC and)
            (NP (NN LPS))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (SBAR (IN that)
              (S
                (SBAR (IN although)
                  (S
                    (NP
                      (NP (DT the) (NN absence))
                      (PP (IN of)
                        (NP (NN ITK))))
                    (VP (VBZ affects)
                      (NP (NN IL-2) (NN secretion))
                      (PP (VBG following)
                        (NP (NN SEB) (NN exposure))))))
                (, ,)
                (NP (PRP$ its) (NN absence))
                (VP (VBZ does) (RB not)
                  (VP (VB affect)
                    (NP
                      (NP (DT the) (NN ability))
                      (PP (IN of)
                        (NP (NN SEB)))
                      (S
                        (VP (TO to)
                          (VP (VB induce)
                            (NP (NN sickness))
                            (PP (IN in)
                              (NP (DT these) (NNS mice)))))))))))))))
    (. .)))

(
  (S
    (NP (NN Discussion))))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADVP (RB well))
        (VP (VBN established)
          (SBAR (IN that)
            (S
              (NP
                (NP (NN exposure))
                (PP (TO to)
                  (NP (NN SEB))))
              (VP (VBZ results)
                (PP (IN in)
                  (NP
                    (NP (JJ large) (NN scale) (NN cytokine) (NN production))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (PP (IN in)
                          (NP (NN part)))
                        (VP (VBZ is)
                          (ADJP (JJ responsible)
                            (PP (IN for)
                              (NP
                                (NP (NNS symptoms))
                                (PP (IN of)
                                  (NP
                                    (NP (NN exposure))
                                    (PP (TO to)
                                      (NP (DT this) (NN toxin) (NN -LSB-1,2,35)))))
                                (-RRB- -RSB-)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN T) (NNS cells))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB be)
                  (ADJP (RB largely) (JJ responsible)
                    (PP (IN for)
                      (NP (DT this) (JJ excessive) (NN cytokine) (NN production) (CD -LSB-35,36))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Current) (NNS suggestions))
        (PP (IN for)
          (S
            (ADVP (RB pharmacologically))
            (VP (VBG blocking)
              (NP
                (NP (DT the) (NNS symptoms))
                (PP (IN of)
                  (NP (NN SEB) (NN exposure))))))))
      (VP (VBP include)
        (NP
          (NP (NN T) (NN cell) (NN signal) (NN transduction) (NNS inhibitors))
          (PP (JJ such) (IN as)
            (NP
              (NP (NN CsA))
              (CC and)
              (NP (NN Perfenidone)))))))
    (, ,)
    (S
      (ADVP (RB however))
      (, ,)
      (NP (DT these) (NNS agents))
      (VP (VBP have)
        (NP
          (NP (JJ significant) (JJ side) (NNS effects))
          (CD -LSB-37,38) (-RRB- -RSB-))))
    (. .)))

(
  (S
    (ADVP (RB Here))
    (NP (PRP we))
    (VP (VBP present)
      (NP
        (NP (DT a) (JJ promising) (NN target))
        (PP (IN for)
          (NP
            (NP (NN inhibition) (NN IL-2) (NN production))
            (VP (VBN induced)
              (PP (IN by)
                (NP
                  (NP (NN SEB) (NN exposure))
                  (, ,)
                  (NP (DT the) (NN tyrosine) (NN kinase) (NN ITK)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP show)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNS mice))
              (VP (VBG lacking)
                (NP (NN ITK))))
            (VP
              (VP (VBP have)
                (NP
                  (ADJP (RB significantly) (VBN reduced))
                  (NN T) (NN cell) (NN expansion)))
              (CC and)
              (VP
                (NP (NN IL-2) (NN secretion))
                (PP (IN upon)
                  (NP
                    (NP (NN exposure))
                    (PP (TO to)
                      (NP
                        (NP (NN SEB))
                        (ADVP (FW in) (FW vivo))))))))))))
    (. .)))

(
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP we))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the)
              (ADJP (NN SEB) (JJ induced))
              (NN signaling) (NN pathway))
            (VP (VBG leading)
              (PP (TO to)
                (NP
                  (NP (NN c-jun) (NN phosphorylation))
                  (, ,)
                  (NP
                    (NP (DT an) (NN indication))
                    (PP (IN of)
                      (NP (NN JNK) (NN pathway) (NN activation))))
                  (, ,)))))
          (VP (VBZ is)
            (VP
              (ADVP (RB significantly))
              (VBN reduced)
              (PP (IN in)
                (NP (NN ITK) (NN null) (NN T) (NNS cells)))
              (, ,)
              (SBAR (IN although)
                (S
                  (S
                    (NP (DT these) (NN T) (NNS cells))
                    (VP (MD could)
                      (VP (VB respond)
                        (PP (TO to)
                          (NP (NN SEB) (NN activation)))
                        (PP (IN by)
                          (S
                            (VP (VBG upregulating)
                              (NP (NN CD69))))))))
                  (, ,)
                  (CC and)
                  (S
                    (NP (EX there))
                    (VP (VBD was)
                      (NP
                        (NP (DT no) (NN difference))
                        (PP (IN in)
                          (NP
                            (NP (DT the) (JJ overall) (NN toxicity))
                            (PP (IN of)
                              (NP (NN SEB/LPS)))))
                        (PP (IN in)
                          (NP (DT these) (NNS mice))))
                      (PP (VBN compared)
                        (PP (TO to)
                          (NP (JJ WT) (NNS mice)))))))))))))
    (. .)))

(
  (S
    (NP
      (NP (JJ Previous) (NN work))
      (VP (VBN performed)
        (ADVP (FW in) (FW vitro))))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NN ITK))
          (VP (VBZ is)
            (VP (VBN required)
              (SBAR (IN for)
                (S
                  (NP (DT the) (JJ anti-TcR/CD3) (NN antibody))
                  (VP (VBD mediated)
                    (NP
                      (NP (NN activation))
                      (PP (IN of)
                        (NP (DT the) (NN transcription) (NN factor) (NN NFAT))))
                    (, ,)
                    (PP (IN via)
                      (NP
                        (NP (NN regulation))
                        (PP (IN of)
                          (NP
                            (NP (NN calcium) (NN influx))
                            (PP (IN into)
                              (NP (NN TcR) (JJ stimulated) (NN T) (NNS cells)
                                (NP (CD -LSB-19,39))))))))
                    (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN ITK) (NN null) (NN T) (NNS cells))
      (ADVP (RB also))
      (VP (VBP exhibit)
        (NP (VBN reduced) (NN AP-1) (NN DNA) (NN binding) (NN activity))
        (SBAR
          (WHADVP (WRB when))
          (S
            (VP (VBN stimulated)
              (ADVP (FW in) (FW vitro))
              (PP (IN with)
                (NP (JJ anti-CD3) (NNS antibodies) (CD -LSB-19) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ has)
        (ADVP (RB also))
        (VP (VBN been)
          (VP (VBN shown)
            (SBAR (IN that)
              (S
                (NP (NN JNK) (NN activation))
                (VP (VBZ lies)
                  (PP (IN in)
                    (NP (NN part)))
                  (ADVP (RB downstream)
                    (PP (IN of)
                      (NP (NN ITK))))
                  (PP (VBG following)
                    (NP (NN TcR) (NN crosslinking)))
                  (PP (IN in)
                    (NP (FW vitro) (NN -LSB-23) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (S
        (ADVP (RB However))
        (, ,)
        (NP (DT these) (NNS experiments))
        (VP (VBD were)
          (VP (VBN performed)
            (ADVP (FW in) (FW vitro)))))
      (CC and)
      (S
        (NP (PRP it))
        (VP (VBZ is) (RB not)
          (ADJP (JJ clear))
          (SBAR (IN that)
            (S
              (NP
                (NP (NNS effects))
                (VP (VBN seen)
                  (ADVP (FW in) (FW vitro))))
              (VP (MD would)
                (VP (VB reflect)
                  (SBAR
                    (WHNP (WP what))
                    (S
                      (VP (VBZ happens)
                        (PP (IN in)
                          (NP (FW vivo)))
                        (, ,)
                        (SBAR (IN since)
                          (S
                            (NP (JJ other) (JJ cell-cell) (NNS interactions))
                            (VP (MD may)
                              (VP (VB allow)
                                (PP (IN for)
                                  (NP
                                    (NP (NN activation))
                                    (PP (IN of)
                                      (NP
                                        (NP (NNS pathways))
                                        (SBAR
                                          (WHNP (WDT that))
                                          (S
                                            (VP (VBP are) (RB not)
                                              (VP (VBN seen)
                                                (S
                                                  (VP (VBG using)
                                                    (NP
                                                      (NP
                                                        (ADJP (FW in) (FW vitro))
                                                        (NN activation))
                                                      (PP (IN with)
                                                        (NP (NNS antibodies))))))))))))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS data))
      (ADVP (RB however))
      (, ,)
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (ADVP (RB indeed))
            (, ,)
            (NP (NN ITK))
            (VP
              (VP (VBZ lies)
                (ADVP (RB downstream)
                  (PP (IN of)
                    (NP (DT the) (NN TcR)))))
              (CC and)
              (VP (VBZ is)
                (VP (VBN required)
                  (PP (IN for)
                    (NP
                      (NP (NN IL-2) (NN secretion))
                      (CC and)
                      (NP (NN c-jun) (NN phosphorylation))))
                  (ADVP (FW in) (FW vivo)))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBG Corroborating)
          (NP
            (NP (DT a) (NN role))
            (PP (IN for)
              (NP (NN c-jun) (NN activation)))
            (PP (IN in)
              (NP (NN IL-2) (NN production))))))
      (, ,)
      (NP
        (NP (NNS mice))
        (VP (VBG carrying)
          (NP (DT a) (JJ dominant) (JJ negative) (NN c-jun))))
      (VP (VBP have)
        (NP
          (NP
            (ADJP (RB much) (VBN reduced))
            (NN IL-2) (NN secretion))
          (ADVP (FW in) (FW vitro))
          (NP
            (NP (CD -LSB-28) (-RRB- -RSB-))
            (PRN (-LRB- -LRB-)
              (S
                (NP
                  (NP (NNS mice))
                  (VP (VBG lacking)
                    (NP (NN c-jun))))
                (VP (VBP die)
                  (PP (IN during)
                    (NP (NN embryogenesis) (CD -LSB-40)))))
              (-RRB- -RSB-) (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Similarly))
      (, ,)
      (NP (NN JNK))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN implicated)
            (PP (IN in)
              (NP
                (NP (NN IL-2) (NN secretion))
                (PP (IN by)
                  (NP (NN T) (NNS cells)))
                (PP (IN in)
                  (NP (FW vitro) (NN -LSB-25-27) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS data))
      (VP (VBP lend)
        (NP (NN support))
        (PP (TO to)
          (NP (DT this) (NN idea)
            (SBAR (IN that)
              (S
                (NP (DT the) (NN JNK-c-jun) (NN pathway))
                (VP (VBZ is)
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN production))
                        (PP (IN of)
                          (NP (NN IL-2)))
                        (PP (IN by)
                          (NP (NN T) (NNS cells)))))
                    (ADVP (FW in) (FW vivo))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Curiously))
      (, ,)
      (NP (DT the) (JJ immunosuppresant) (NN CsA))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB inhibit)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP (NN SEB) (NN exposure)))
                    (PP (IN in)
                      (NP (NNS mice))))
                  (SBAR (IN if)
                    (S
                      (VP (VBN delivered)
                        (PP (JJ prior) (TO to)
                          (NP (NN SEB) (NN exposure) (CD -LSB-36) (-RRB- -RSB-)))))))))))))
    (, ,)
    (S
      (ADVP (RB however))
      (NP (PRP it))
      (VP (VBZ does) (RB not)
        (VP (VB inhibit)
          (NP
            (ADJP (NN SEB) (JJ induced))
            (NNS effects))
          (PP (IN in)
            (NP (NNS monkeys)))
          (SBAR (IN if)
            (S
              (VP (VBN delivered)
                (PP (IN at)
                  (NP (DT the) (JJ same) (NN time)))
                (PP (IN as)
                  (NP (NN SEB) (CD -LSB-38)))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS effects))
        (PP (IN of)
          (NP (NN CsA)))
        (PP (IN on)
          (NP
            (ADJP (NN SEB) (JJ induced))
            (NNS symptoms))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN suggested)
            (S
              (VP (TO to)
                (VP (VB be)
                  (ADJP (JJ due)
                    (PP (TO to)
                      (NP
                        (NP (PRP$ its) (NNS effects))
                        (PP (IN on)
                          (S
                            (VP (VBG inhibiting)
                              (NP
                                (NP (NN IL-2)
                                  (CC and)
                                  (JJ other) (NN cytokine) (NN production))
                                (ADJP (JJ due)
                                  (PP (TO to)
                                    (NP
                                      (NP (NN inhibition))
                                      (PP (IN of)
                                        (NP
                                          (NP (NN activation))
                                          (PP (IN of)
                                            (NP
                                              (NP (DT the) (NN transcription) (NN factor) (NN NFAT) (CD -LSB-36,41) (-RRB- -RSB-))
                                              (PRN (, ,)
                                                (S
                                                  (ADVP (RB however))
                                                  (, ,)
                                                  (NP (NN CsA))
                                                  (ADVP (RB also))
                                                  (VP (VBZ inhibits)
                                                    (NP
                                                      (NP (NN activation))
                                                      (PP (IN of)
                                                        (NP (DT the) (NN JNK) (NN pathway))))
                                                    (PP (VBG following)
                                                      (NP
                                                        (NP
                                                          (NP (NN TcR/CD3))
                                                          (CC and)
                                                          (NP (NN CD28)))
                                                        (NN stimulation) (CD -LSB-29,30)))))
                                                (-RRB- -RSB-)))))))))))))))))))))))
    (, ,)
    (CC and)
    (RB so)
    (S
      (NP (NN CsA) (NN pretreatment))
      (VP (MD may)
        (VP (VB act)
          (S
            (VP (TO to)
              (VP (VB prevent)
                (NP
                  (NP (JJ early) (NN T) (NN cell) (NN activation))
                  (PP (IN of)
                    (NP (DT these) (NNS pathways))))))))
        (, ,)
        (S
          (ADVP (RB thus))
          (VP
            (VP (VBG blocking)
              (NP (NN cytokine) (NN production)))
            (CC and)
            (VP (VBG protecting)
              (NP (NNS mice))
              (PP (IN from)
                (NP
                  (NP (DT the) (NNS effects))
                  (PP (IN of)
                    (NP (JJ subsequent) (NN SEB) (NN exposure))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Mice))
        (VP (VBG lacking)
          (NP (NN ITK))))
      (VP
        (VP (VBP exhibit)
          (NP (VBN reduced) (NN T) (NN cell) (NNS responses))
          (ADVP (FW in) (FW vitro)))
        (, ,)
        (CC but)
        (ADVP (RB also))
        (VP (VBP have)
          (NP
            (NP (VBN reduced) (NNS percentages))
            (PP (IN of)
              (NP (JJ CD4+) (NN T) (NNS cells))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP
                (QP (RB approximately) (CD 60–70))
                (NN %))
              (PP (IN of)
                (NP (NN WT))))
            (, ,)
            (NP (CD -LSB-16) (-RRB- -RSB-))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (SBAR (IN While)
      (S
        (NP (DT this))
        (VP (MD would)
          (VP (VB be)
            (VP (VBN expected)
              (S
                (VP (TO to)
                  (VP (VBD reduced)
                    (NP (DT the) (JJ overall) (NN T) (NN cell) (NN response))
                    (ADVP (FW in) (FW vivo))
                    (PP (TO to)
                      (NP (NN SEB) (NN exposure)))))))))))
    (, ,)
    (SBAR (IN if)
      (S
        (NP (DT these) (NNS cells))
        (VP (VBD were)
          (ADJP (JJ able)
            (S
              (VP (TO to)
                (VP (VB respond)
                  (PP (TO to)
                    (NP (NN SEB))))))))))
    (, ,)
    (NP (PRP we))
    (VP (MD would)
      (VP (VB expect)
        (NP
          (NP (DT an) (JJ equivalent) (NN reduction))
          (PP (IN in)
            (NP
              (NP (DT the) (NN amount))
              (PP (IN of)
                (NP
                  (NP (NN IL-2))
                  (VP (VBN secreted)
                    (ADVP (FW in) (FW vivo))
                    (PP (IN in)
                      (NP
                        (NP (NN response))
                        (PP (TO to)
                          (NP (NN SEB)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (MD would)
        (ADVP (RB also))
        (VP (VB expect)
          (S
            (VP (TO to)
              (VP (VB see)
                (NP
                  (NP (DT an) (JJ equivalent) (NN reduction))
                  (PP (IN in)
                    (NP (NN proliferation))))
                (ADVP (FW in) (FW vitro))))))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (, ,)
    (PP (IN in)
      (NP (FW vivo)))
    (, ,)
    (NP (PRP we))
    (VP
      (VP
        (VP (VBD observed)
          (NP
            (ADJP (RB much) (VBN reduced))
            (NN IL-2) (NN secretion)))
        (, ,)
        (CC and)
        (VP (VBD reduced)
          (NP
            (NP (NN expansion))
            (PP (IN of)
              (NP (NN Vβ8+CD4+) (NN T) (NNS cells))))))
      (, ,)
      (SBAR (IN although)
        (S
          (NP (DT this))
          (VP (VBD was) (RB not)
            (ADJP (RB as) (JJ dramatic)
              (PP (IN as)
                (NP
                  (NP (DT the) (NN reduction))
                  (PP (IN in)
                    (NP (NN IL-2) (NN secretion))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Indeed))
      (, ,)
      (NP (PRP it))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN observed)
            (SBAR (IN that)
              (S
                (NP (NN SEB))
                (VP (VBD induced)
                  (NP (NN T) (NN cell) (NN expansion))
                  (PP (IN in)
                    (NP (NN IL-2) (JJ null) (NNS mice)))
                  (, ,)
                  (S
                    (VP (VBG indicating)
                      (SBAR (IN that)
                        (S
                          (NP (NN IL-2))
                          (VP (VBZ is) (RB not)
                            (ADJP (JJ necessary)
                              (PP (IN for)
                                (NP
                                  (NP (NN expansion))
                                  (PP (IN of)
                                    (NP (NN T) (NNS cells)))))
                              (ADVP (FW in) (FW vivo)))
                            (PP (VBG following)
                              (NP (NN SEB) (NN exposure)))))))))))))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (, ,)
    (PP
      (ADVP (RB even))
      (IN with)
      (NP
        (NP (DT the) (VBN reduced) (NN T) (NN cell) (NNS responses))
        (VP (VBN observed)
          (PP (IN in)
            (NP (NN ITK) (JJ null) (NNS mice))))))
    (, ,)
    (NP (PRP they))
    (ADVP (RB still))
    (VP (VBP suffer)
      (PP (IN from)
        (NP
          (NP (JJ SEB/LPS) (JJ induced) (NN toxicity))
          (ADJP (JJ similar)
            (PP (TO to)
              (NP
                (NP (DT that))
                (VP (VBN seen)
                  (PP (IN in)
                    (NP (DT the) (JJ WT) (NNS mice))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (MD should)
        (VP (VB be)
          (VP (VBN noted)
            (ADVP (RB however))
            (, ,)
            (SBAR (IN that)
              (S
                (NP (NN C57BL/6) (NNS mice))
                (VP (VBP are)
                  (ADJP
                    (ADVP (RB much) (RBR less))
                    (JJ sensitive)
                    (PP (TO to)
                      (NP
                        (NP (NN SEB))
                        (PRN
                          (S
                            (VP (VB induce)
                              (NP (JJ lethal) (NN shock))
                              (PP (IN than)
                                (NP (NN Balb/c) (NNS mice) (CD -LSB-34)))))
                          (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (ADVP (RB Thus))
        (NP (PRP we))
        (VP (VBD observed)
          (NP
            (ADJP (RB very) (JJ few))
            (NNS deaths))
          (PP (IN in)
            (NP (PRP$ our) (NNS experiments)))))
      (, ,)
      (CC and)
      (S
        (NP (NN ITK))
        (VP (MD may)
          (VP (VB protect)
            (NP (NN Balb/c) (NNS mice))
            (PP (IN from)
              (NP (JJ actual) (NN death)))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP are)
        (ADVP (RB currently))
        (VP (VBG crossing)
          (NP (DT these) (NNS mice))
          (PP (IN onto)
            (NP (DT the) (NN Balb/c) (NN background)))
          (S
            (VP (TO to)
              (VP (VB determine)
                (SBAR (IN if)
                  (S
                    (NP (DT this))
                    (VP (VBZ is)
                      (NP (DT the) (NN case)))))))))))
    (. .)))

(
  (S
    (NP (NN Conclusion))))

(
  (S
    (S
      (PP (IN In)
        (NP (NN conclusion)))
      (, ,)
      (NP (PRP we))
      (VP (VBP have)
        (VP (VB show)
          (SBAR (IN that)
            (S
              (NP (NN ITK))
              (VP (VBZ is)
                (VP (VBN required)
                  (PP (IN for)
                    (NP
                      (NP (NN IL-2) (NN production))
                      (VP (VBN induced)
                        (PP (IN by)
                          (NP (NN SEB))))))
                  (ADVP
                    (ADVP (FW in) (FW vivo))
                    (CC and)
                    (ADVP (FW in) (FW vitro))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (ADVP (RB also))
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (NN ITK))
              (VP (MD may)
                (VP (VB regulate)
                  (NP
                    (NP (NNS signals))
                    (VP (VBG leading)
                      (NP (NN IL-2) (NN production))))
                  (PP (IN in)
                    (NP (NN part)))
                  (PP (IN by)
                    (S
                      (VP (VBG regulating)
                        (NP
                          (NP (NN phosphorylation))
                          (PP (IN of)
                            (NP (NN c-jun))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP
        (NP (NNS mice))
        (VP (VBG lacking)
          (NP (NN ITK))))
      (VP (VBP exhibit)
        (NP
          (NP (JJ similar) (NNS responses))
          (PP (TO to)
            (NP (NN SEB) (NN toxicity))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS data))
      (VP (VBP suggest)
        (SBAR
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (NN inability))
                (PP (IN of)
                  (NP (NN T) (NN cell) (VBG lacking) (NN ITK)))
                (S
                  (VP (TO to)
                    (VP (VB produce)
                      (NP (NN IL-2))))))
              (VP (MD cannot)
                (VP (VB be)
                  (VP (VBN overcome)
                    (PP (IN by)
                      (NP (NN SAG) (NN stimulation))))))))
          (, ,)
          (CC and)
          (SBAR (IN that)
            (S
              (S
                (VP (VBG perturbing)
                  (NP
                    (NP (NN T) (NN cell) (NN activation) (NNS pathways))
                    (VP (VBG leading)
                      (PP (TO to)
                        (NP (NN IL-2) (NN production)))))))
              (VP (VBZ does) (RB not)
                (ADVP (RB necessarily))
                (VP (VB lead)
                  (PP (TO to)
                    (NP
                      (NP (JJ improved) (NNS responses))
                      (PP (TO to)
                        (NP (NN SEB) (NN toxicity))))))))))))
    (. .)))

(
  (S
    (NP (NNS Methods))))

(
  (S
    (S
      (NP
        (NP
          (NP (JJ Wild) (NN type) (NNS mice))
          (CC and)
          (NP
            (NP (JJ ITK-deficient) (NNS mice))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NN C57BL/6) (NN background))
                (, ,)
                (NP (CD -LSB-16) (-RRB- -RSB-)))
              (-RRB- -RRB-))))
        (PP (IN between)
          (NP (CD 8)
            (CC and)
            (CD 10) (NNS weeks))))
      (VP (VBD were)
        (VP (VBN used)
          (PP (IN in)
            (NP (DT all) (NNS experiments))))))
    (. .)))

(
  (S
    (S
      (NP (JJ RAG1-/-) (NNS mice))
      (VP
        (VP (VBD were)
          (NP
            (NP (DT a) (NN kind) (NN gift))
            (PP (IN of)
              (NP
                (NP (NNP Dr.) (NN Eric) (NNP Harvill))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Penn) (NN State) (NNP University))
                  (-RRB- -RRB-))))))
        (CC and)
        (VP (VBD were)
          (ADVP (RB similarly))
          (VP (VBN used)
            (PP (IN between)
              (NP
                (NP (CD 6–10) (NNS weeks))
                (PP (IN of)
                  (NP (NN age)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ Institutional) (NN Animal) (NN Care)
          (CC and)
          (NN Use) (NN Committee))
        (PP (IN of)
          (NP (DT The) (NNP Pennsylvania) (NN State) (NNP University))))
      (VP (JJ approved)
        (NP (DT all) (NNS experiments))))
    (. .)))

(
  (S
    (S
      (NP (NN WT)
        (CC and)
        (NN ITK) (JJ deficient) (NNS mice))
      (VP (VBD were)
        (VP (VBN injected)
          (ADVP
            (ADVP (RB intraperitoneally))
            (PRN (-LRB- -LRB-)
              (ADVP (RB i.p.))
              (-RRB- -RRB-)))
          (PP (IN with)
            (NP
              (ADJP (CD 50) (NN μg))
              (NN SEB)))
          (SBAR (IN in)
            (S (NN PBS) (-LRB- -LRB-) (NNP Sigma-Aldrich) (, ,) (NN St.) (NN Louis) (, ,) (NN MO) (-RRB- -RRB-)
              (CC and)
              (PP (IN after)
                (NP (CD 2) (NNS days)))
              (, ,)
              (VP (VBD were)
                (VP (VBN sacrificed)
                  (NP (CC and)
                    (NP
                      (NP (NNS splenocytes))
                      (VP (VBN stained)
                        (PP (IN with)
                          (NP
                            (NP (NNS antibodies))
                            (ADJP (JJ specific)
                              (PP (IN for)
                                (NP (NN Vβ8))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NN SEB) (JJ reactive) (NN T) (NNS cells))
                          (-RRB- -RRB-))))
                    (CC or)
                    (NP
                      (NP
                        (NP
                          (NP (NN Vβ6))
                          (PRN (-LRB- -LRB-)
                            (NP (JJ non-reactive) (NN T) (NNS cells))
                            (-RRB- -RRB-)))
                        (CC and)
                        (NP (NN CD4)))
                      (VP
                        (ADVP (RB directly))
                        (VBN conjugated)
                        (PP (TO to)
                          (NP
                            (NP (NN FITC))
                            (CC and)
                            (NP (NN PE)))))))
                  (ADVP
                    (ADVP (RB respectively))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NNP BDPharmingen) (, ,) (NNP San) (NNP Diego))
                        (, ,)
                        (NP (NN CA)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Alternatively))
      (, ,)
      (NP (NNS mice))
      (VP (VBD were)
        (VP
          (VP (VBN injected)
            (ADVP (RB i.p.))
            (PP (IN with)
              (NP
                (ADJP (CD 50) (NN μg))
                (NN SEB))))
          (CC and)
          (VP (VBN eye-bled)
            (NP (DT every) (CD 2) (NNS days))
            (PP (IN for)
              (NP (CD 5) (NNS days)))))))
    (. .)))

(
  (S
    (S
      (PP (VBG Following)
        (NP
          (NP (NN lysis))
          (PP (IN of)
            (NP (JJ red) (NN blood) (NNS cells)))))
      (, ,)
      (NP (DT the) (VBG remaining) (NNS cells))
      (VP (VBD were)
        (VP (VBN stained)
          (SBAR (IN as)
            (S
              (VP (VBN described)
                (ADVP (RB above))
                (PP (IN for)
                  (NP (DT the) (NNS splenocytes)))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Lymphocytes))
      (VP (VBD were)
        (VP (VBN identified)
          (PP (IN by)
            (NP (NN flow) (NN cytometry)))
          (PP (IN by)
            (NP (PRP$ their)
              (ADJP
                (ADJP (JJ forward))
                (CC and)
                (ADJP (JJ side))
                (ADJP (JJ scatter)))
              (NNS characteristics))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD used)
        (NP
          (NP (DT a) (NN protocol))
          (VP (VBN reported)
            (PP (IN by)
              (NP (NNP Zell) (FW et) (FW al)))))
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (NN phosphorylation) (NN status))
                (PP (IN of)
                  (NP (NN c-jun))))
              (, ,)
              (PP (IN as)
                (NP
                  (NP (DT a) (NN measure))
                  (PP (IN of)
                    (NP
                      (NP (NN activation))
                      (PP (IN of)
                        (NP
                          (NP (DT the) (JJ JNK-c-jun) (NN pathway))
                          (PP (IN in)
                            (NP (NN SEB) (VBG responding) (NN T) (NNS cells))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN WT))
          (CC and)
          (NP (NN ITK)))
        (JJ deficient) (NNS mice))
      (VP (VBD were)
        (VP
          (VP (VBN injected)
            (ADVP
              (ADVP (RB i.p.))
              (CC or)
              (ADVP
                (ADVP (RB intravenously))
                (PRN (-LRB- -LRB-)
                  (NP (NN i.v.))
                  (-RRB- -RRB-))))
            (PP (IN with)
              (NP
                (ADJP (CD 50) (NN μg))
                (NN SEB))))
          (CC and)
          (VP (VBN allowed)
            (S
              (VP (TO to)
                (VP (VB survive)
                  (PP (IN for)
                    (NP (DT an) (CD 1) (NN hr))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Similar) (NNS results))
      (VP (VBD were)
        (VP (VBN found)
          (PP (IN with)
            (NP
              (NP (DT both) (NNS routes))
              (PP (IN of)
                (NP (NN administration))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Animals))
        (VP (VBD were)
          (VP (VBN sacrificed))))
      (CC and)
      (S
        (NP
          (NP (NNS spleens))
          (, ,)
          (NP (NN lymph) (NNS nodes))
          (, ,)
          (CC and)
          (NP (NN blood)))
        (ADVP (RB rapidly))
        (VP
          (VP (VBN isolated))
          (, ,)
          (CC and)
          (VP (VBN dounced)
            (PP (IN in)
              (NP
                (ADJP (CD 2) (NN %))
                (NN paraformaldehyde)))
            (S
              (VP (TO to)
                (ADVP (RB rapidly))
                (VP (VB fix)
                  (NP (DT the) (NNS cells))
                  (PP (IN as)
                    (NP
                      (ADJP (RB previously) (VBN described))
                      (NN -LSB-30)))
                  (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (VP (VBN stained)
          (PP (IN with)
            (NP
              (NP (NNS antibodies))
              (PP (TO to)
                (NP
                  (NP (NNP Vβ8))
                  (CC or)
                  (NP (NNP Vβ6))))
              (VP
                (ADVP (RB directly))
                (VBN conjugated)
                (PP (TO to)
                  (NP (NN PE)))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP BDPharmingen) (, ,) (NNP San) (NNP Diego))
                    (, ,)
                    (NP (NN CA)))
                  (-RRB- -RRB-)))))
          (, ,)
          (ADVP (RB then))
          (ADJP (JJ permeabilized)
            (PP (IN with)
              (NP (NN saponin)))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN stained)
          (PP (IN for)
            (NP (JJ intracellular) (NN phosphorylated-c-jun)))
          (PP (IN with)
            (NP
              (NP (DT a) (JJ monoclonal) (NN antibody))
              (PP (IN against)
                (NP
                  (NP
                    (NP (VBN phosphorylated) (NN c-jun))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NN IgG1))
                        (, ,)
                        (NP (NN Cell) (NN Signaling))
                        (, ,)
                        (NP (NNP Beverly) (, ,) (NNP MA)))
                      (-RRB- -RRB-)))
                  (, ,)
                  (VP (VBN followed)
                    (PP (IN by)
                      (NP
                        (NP
                          (NP (VBN biotinylated) (NN rabbit) (JJ anti-mouse) (NN IgG1))
                          (CC and)
                          (NP (NN streptavidin)))
                        (VP (VBN conjugated)
                          (PP (TO to)
                            (NP (NN FITC))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Controls))
      (VP (VBD included)
        (NP
          (NP (JJ secondary) (NNS reagents))
          (ADVP (RB alone)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Upregulation))
        (PP (IN of)
          (NP (NN CD69)))
        (PP (IN by)
          (NP (NN SEB)))
        (ADVP (FW in) (FW vivo)))
      (VP (VBD was)
        (VP (VBN performed)
          (S
            (VP (VBG using)
              (NP
                (NP (JJ similar) (NNS approaches))
                (, ,)
                (SBAR
                  (WHPP (IN except)
                    (WHNP (WDT that)))
                  (S
                    (NP (NN T) (NNS cells))
                    (VP (VBD were) (RB not)
                      (ADJP
                        (ADJP (JJ fixed))
                        (CC or)
                        (ADJP (JJ permeabilized)))
                      (PP (JJ prior) (TO to)
                        (NP
                          (NP (NN staining))
                          (PP (IN with)
                            (NP
                              (NP (JJ PE-conjugated) (NN anti-CD69) (JJ monoclonal) (NN antibody))
                              (PRN (-LRB- -LRB-)
                                (NP
                                  (NP (NNP BDPharmingen) (, ,) (NNP San) (NNP Diego))
                                  (, ,)
                                  (NP (NN CA)))
                                (-RRB- -RRB-)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBD was)
        (VP (VBN followed)
          (PP (IN by)
            (NP (NN analysis)))
          (PP (IN by)
            (NP (NN flow) (NN cytometry)))
          (, ,)
          (PP (IN with)
            (NP
              (NP (JJ post) (NN analysis))
              (VP (VBN performed)
                (S
                  (VP (VBG using)
                    (NP
                      (NP (DT the) (NN WinMDI) (NN program) (CD 2.8))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (DT The) (NN Scripps) (NN Research) (NN Institute))
                          (, ,)
                          (NP (NN La) (NN Jolla))
                          (, ,)
                          (NP (NN CA)))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Lymph) (NNS nodes))
        (CC and)
        (NP (NNS spleens)))
      (VP (VBD were)
        (VP
          (VP (VBN isolated)
            (PP (IN from)
              (NP
                (NP
                  (NP (NN WT))
                  (CC and)
                  (NP (NN ITK)))
                (JJ deficient) (NNS mice))))
          (CC and)
          (VP (JJ pooled)))))
    (. .)))

(
  (S
    (S
      (S
        (NP (JJ Red) (NN blood) (NNS cells))
        (VP (VBD were)
          (VP (VBN removed)
            (S
              (VP (VBG using)
                (NP (NN ACK) (NN lysis) (NN buffer)))))))
      (, ,)
      (CC and)
      (S
        (NP (NNS cells))
        (VP (VBN resuspended)
          (PP (IN in)
            (NP (JJ complete) (NN RPMI))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (ADVP (RB then))
        (ADJP (JJ left))
        (UCP
          (ADJP (JJ unstimulated))
          (CC or)
          (VP (VBN stimulated)
            (PP (IN with)
              (NP
                (NP (JJ varying) (NNS concentrations))
                (PP (IN of)
                  (NP
                    (NP (NN SEB))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 5) (NN μg/ml))
                        (, ,)
                        (NP (CD 0.5) (NN μg/ml))
                        (, ,)
                        (NP (CD 0.05) (NN μg/ml))
                        (, ,)
                        (NP (CD 0.005) (NN μg/ml))
                        (, ,)
                        (CC and)
                        (NP (CD 0.0005) (NN μg/ml)))
                      (-RRB- -RRB-))))))
            (PP (IN at)
              (NP
                (NP (DT a) (NN concentration))
                (PP (IN of)
                  (NP (CD 2) (NN ×) (CD 106) (NNS cells/ml)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN incubated)
            (PP (IN at)
              (NP (NN 37°C)))
            (PP (IN for)
              (NP (CD 5) (NNS days))))
          (CC and)
          (VP (VBN pulsed)
            (PP (IN once)
              (NP
                (NP (DT a) (NN day))
                (PP (IN for)
                  (NP (CD 5) (NNS days)))))
            (PP (IN with)
              (NP
                (NP
                  (ADJP (CD 0.5) (NN μCi))
                  (JJ tritiated) (NN thymidine))
                (PP (IN per)
                  (NP (NN well)))
                (PP (IN for)
                  (NP (CD 12) (NNS hrs)))))))))
    (. .)))

(
  (S
    (PP (IN before)
      (NP (NN harvest)))
    (. .)))

(
  (S
    (S
      (NP (NN T) (NNS cells))
      (VP (VBD were)
        (VP (VBN purified)
          (PP (IN from)
            (NP (NN WT)
              (CC and)
              (NN ITK) (JJ null) (NNS mice)))
          (S
            (VP (VBG using)
              (NP
                (NP
                  (NP (NN MiniMACS) (NN separation) (NNS columns))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Miltenyi) (NNP Biotec) (NNP Inc) (, ,) (NNP Auburn))
                    (, ,)
                    (NP (NN CA))
                    (-RRB- -RRB-)))
                (, ,)
                (VP (CC and)
                  (VP (VBN plated)
                    (PP (IN at)
                      (NP (CD 2) (NN ×) (CD 106) (NNS cells/ml))))
                  (CC and)
                  (VP (VBN stimulated)
                    (PP (IN as)
                      (NP (JJ above)))))
                (, ,))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN presence))
                  (PP (IN of)
                    (NP
                      (NP (NNS splenocytes))
                      (PP (IN from)
                        (NP (NN RAG) (JJ null) (NNS mice)))
                      (VP (VBN pre-treated)
                        (PP (IN with)
                          (S
                            (NP (NN mitomycin) (NN C.) (NN All) (NNS experiments))
                            (VP (VBD were)
                              (VP (VBN done)
                                (PP (IN in)
                                  (NP (NN triplicate)))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (JJ Pooled) (NNS lymphocytes))
          (CC and)
          (NP (NNS splenocytes)))
        (PP (IN from)
          (NP
            (NP
              (NP (NN WT))
              (CC and)
              (NP (NN ITK)))
            (JJ deficient) (NNS mice))))
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN with)
            (NP
              (NP (JJ varying) (NNS concentrations))
              (PP (IN of)
                (NP
                  (NP (NN SEB))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 5) (NN μg/ml))
                      (, ,)
                      (NP (CD 0.5) (NN μg/ml))
                      (, ,)
                      (NP (CD 0.05) (NN μg/ml))
                      (, ,)
                      (NP (CD 0.005) (NN μg/ml))
                      (, ,)
                      (CC and)
                      (NP (CD 0.0005) (NN μg/ml)))
                    (-RRB- -RRB-))))))
          (PP (IN for)
            (NP (CD 5) (NNS days)))
          (SBAR (IN as)
            (S
              (VP (VBN described)
                (ADVP (RB above))
                (PP (IN for)
                  (NP
                    (ADJP (FW in) (FW vitro))
                    (NN proliferation)))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Supernatants))
      (VP (VBD were)
        (VP
          (VP (VBN sampled)
            (PP (IN once)
              (NP (DT a) (NN day)))
            (PP (IN over)
              (NP (DT this) (NN period))))
          (CC and)
          (VP (VBN analyzed)
            (PP (IN for)
              (NP (NN IL-2)))
            (S
              (VP (VBG using)
                (NP
                  (NP (NNS ELISAs))
                  (VP (VBG according)
                    (PP (TO to)
                      (NP
                        (NP
                          (NP (DT the) (NN manufacturer) (POS 's))
                          (NNS recommendations))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (NNP BDPharmingen) (, ,) (NNP San) (NNP Diego))
                            (, ,)
                            (NP (NN CA)))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN WT)
          (CC and)
          (NN ITK) (JJ deficient) (NNS mice))
        (VP (VBD were)
          (VP (VBN injected)
            (PP (IN with)
              (NP
                (ADJP (CD 50) (NN μg))
                (NN SEB) (NN i.v.))))))
      (, ,)
      (CC and)
      (S
        (NP (NN serum))
        (VP (VBN isolated)
          (PP (IN from)
            (NP
              (NP (JJ cardiac) (NN blood))
              (PP (IN from)
                (NP (NNS mice)
                  (QP (CD 1) (, ,) (CD 2) (, ,) (CD 4) (, ,) (CD 8) (, ,) (CD 12) (, ,)
                    (CC and)
                    (CD 24))
                  (NNS hrs))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ post) (NN SEB) (NN exposure))
      (VP (CC and)
        (VP (VBN used)
          (S
            (VP (TO to)
              (VP (VB perform)
                (NP (DT an) (NN ELISA)
                  (S
                    (VP (TO to)
                      (VP (VB determine)
                        (NP (NN IL-2) (NNS levels))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (JJ PBS) (VBN injected) (NNS mice))
        (VP (VBD served)
          (PP (IN as)
            (NP (NNS controls)))))
      (, ,)
      (CC and)
      (S
        (NP (EX there))
        (VP (VBD was)
          (NP
            (NP (DT no) (NN change))
            (PP (IN in)
              (NP (NN IL-2) (NN secretion)))
            (PP (IN in)
              (NP (DT these) (NNS animals)))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Values))
      (VP
        (VP (VBD were)
          (VP (VBN compared)
            (S
              (VP (VBG using)
                (NP
                  (NP (NN student) (POS 's))
                  (NN t) (NN test))))))
        (CC and)
        (VP (VBD considered)
          (ADJP (JJ significant)
            (PP (IN if)
              (NP (NN p) (NN <) (CD 0.05)))))))
    (. .)))

(
  (S
    (NP
      (NP (NN List))
      (PP (IN of)
        (NP
          (NP (NNS abbreviations))
          (VP (VBN used)))))))

(
  (S
    (NP
      (NP (NN ITK))
      (NP (NN Interleukin-2) (JJ inducible) (NN T) (NN cell) (NN Kinase)))))

(
  (S
    (NP (NN IL-2) (NN Interleukin-2))))

(
  (S
    (NP (NN SEB) (JJ Staphylococcal) (NN Enterotoxin) (NN B))))

(
  (S
    (NP (NN SAG) (NN Superantigen))))

(
  (S
    (NP (NN Th1) (NN T-helper) (CD 1) (NNS cells))))

(
  (S
    (NP (NN Th2) (NN T-helper) (CD 2) (NNS cells))))

(
  (S
    (NP (NN Syk) (NN Spleen) (NN tyrosine) (NN kinase))))

(
  (S
    (NP (NN Zap-70) (NN Zeta) (NN chain) (JJ Associated) (CD protein-70))))

(
  (S
    (NP
      (NP (NN Lck))
      (NP (NN Lstra) (NN cell) (NN kinase)))))

(
  (S
    (NP (NN MAPK) (NN Mitogen) (JJ Activated) (NN Protein) (NN Kinase))))

(
  (S
    (NP (NN ERK) (JJ Extracellular) (NN signal) (JJ Regulated) (NN Kinase))))

(
  (S
    (NP (NN JNK) (NN c-jun) (JJ N-terminal) (NN kinase))))

(
  (S
    (NP (NN NK) (JJ Natural) (NN Killer) (NNS cells))))

(
  (S
    (NP (NN LCM) (JJ Lymphocytic) (NN Choriomeningitis))))

(
  (S (CC VS)
    (NP (NN Vesicular) (NN Stomatitis))))

(
  (S
    (NP (NN PMA) (NN Phorbol) (JJ Myristic) (NN Acid))))

(
  (S
    (NP (JJ PBS) (NN Phosphate) (JJ Buffered) (NN Saline))))

(
  (S
    (NP
      (NP (NN NFAT) (JJ Nuclear) (NN Factor))
      (PP (IN of)
        (NP (JJ Activated) (NN T) (NNS cells))))))

(
  (S
    (NP (NN AP-1) (NN Activator) (NN protein) (CD 1))))

(
  (S
    (NP
      (NP (NN CsA))
      (NP (NN Cyclosporin) (NN A)))))

(
  (S
    (NP
      (NP (NNS Authors) (POS '))
      (NNS contributions))))

(
  (S
    (S
      (NP (NN AA))
      (VP (VBN designed)
        (NP (DT the) (NNS experiments))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN MJR))
          (CC and)
          (NP (NN JH)))
        (VP (VBN performed)
          (NP
            (NP
              (NP (NNS experiments))
              (VP (VBG leading)
                (PP (TO to)
                  (NP (NN figure)
                    (LST (LS 1.))
                    (NN MJR)))))
            (VP (VBN performed)
              (NP
                (NP (NNS experiments))
                (VP (VBG leading)
                  (PP (TO to)
                    (NP (NNS figures)
                      (NP
                        (NP
                          (QP (CD 2) (, ,) (CD 3) (, ,) (CD 4) (, ,) (CD 5) (, ,) (CD 6) (, ,) (CD 7.))
                          (NN AA))
                        (CC and)
                        (NP (NN AJH)))))))))))
      (VP (VBD provided)
        (NP
          (NP (JJ financial) (NN support))
          (CC and)
          (NP (NN supervision)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN MJR))
        (, ,)
        (NP (NN AJH))
        (CC and)
        (NP (NN AA)))
      (VP (VBP wrote)
        (NP (DT the) (NN manuscript))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS authors))
      (VP
        (VP (VBN read))
        (CC and)
        (VP (JJ approved)
          (NP (DT the) (JJ final) (NN manuscript)))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure))
      (CC and)
      (NP (NN Table))
      (NP (NNS captions)))))

(
  (S
    (S
      (NP (NN Figure) (CD 1) (: :) (NN ITK))
      (VP (VBZ regulates)
        (NP (NN proliferation))
        (ADVP (FW in) (FW vitro))
        (PP (IN in) (NN response) (TO to)
          (NP (NN SEB)))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP
            (NP (NNS Splenocytes))
            (CC and)
            (NP
              (NP (NN lymph) (NN node))
              (NNS cells)))
          (PP (IN from)
            (NP
              (ADJP
                (ADJP (JJ WT))
                (PRN (-LRB- -LRB-)
                  (NP (JJ filled) (NNS circles))
                  (-RRB- -RRB-))
                (CC and)
                (ADJP (NN ITK) (JJ deficient))
                (PRN (-LRB- -LRB-)
                  (NP (JJ open) (NNS circles))
                  (-RRB- -RRB-)))
              (NNS mice))))
        (VP (VBD were)
          (VP (VBN stimulated)
            (ADVP (FW in) (FW vitro))
            (PP (IN with)
              (NP
                (NP (DT the) (VBN indicated) (NNS concentrations))
                (PP (IN of)
                  (NP (NN SEB))))))))
      (, ,)
      (CC and)
      (S
        (NP (JJ proliferative) (NN response))
        (VP (VBN determined))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Time) (NN course))
        (PP (IN of)
          (NP (NN proliferation)))
        (PP (IN over)
          (NP
            (NP (DT the) (VBN indicated) (NNS doses))
            (PP (IN of)
              (NP (NN SEB))))))
      (LST (LS a) (-RRB- -RRB-))
      (NP
        (NP (CD 5) (NN μg/ml) (NN SEB) (, ,) (NN b) (-RRB- -RRB-) (NN dose) (NN curve))
        (PP (IN of)
          (NP
            (QP (CD 0.0005) (, ,) (CD 0.005) (, ,) (CD 0.05) (, ,) (CD 0.5) (, ,))
            (NN &) (CD 5) (NN μg/ml) (NN SEB))))
      (VP (VBN analyzed)
        (PP (IN at)
          (NP
            (NP (CD 5) (NNS days))
            (PP (IN post)
              (NP (NN stimulation)))))))
    (. .)))

(
  (S
    (S
      (VP (VBN Purified)
        (NP
          (NP
            (NP
              (NP
                (S
                  (NP
                    (ADJP
                      (ADJP (JJ WT))
                      (PRN (-LRB- -LRB-)
                        (NP (JJ filled) (NNS circles))
                        (-RRB- -RRB-))
                      (CC and)
                      (ADJP (NN ITK) (JJ deficient))
                      (PRN (-LRB- -LRB-)
                        (NP (JJ open) (NNS circles))
                        (-RRB- -RRB-)))
                    (NN T) (NNS cells))
                  (VP (VBD were)
                    (VP
                      (VP (VBN stimulated)
                        (PP (IN in)
                          (NP (FW vitro)))
                        (PP (IN over)
                          (NP
                            (NP
                              (NP (DT the) (VBN indicated) (NN time))
                              (PP (IN with)
                                (NP (NN c) (-RRB- -RRB-) (CD 10) (NN μg/ml) (NN SEB))))
                            (, ,)
                            (CC or)
                            (NP
                              (NP (DT a) (NN dose) (NN curve))
                              (PP (IN of)
                                (NP
                                  (QP (CD 0.01) (, ,) (CD 0.1) (, ,) (CD 1) (, ,)
                                    (CC and)
                                    (CD 10))
                                  (NN μg/ml) (NN SEB)))))))
                      (CC and)
                      (VP (VBN analyzed)
                        (PP (IN at)
                          (NP (NN d)))))))
                (-RRB- -RRB-) (CD 3) (NNS days))
              (PRN (, ,)
                (NP (NN e))
                (-RRB- -RRB-)))
            (NP (CD 4) (NNS days))
            (CC or)
            (NP (NN f) (-RRB- -RRB-) (CD 5) (NNS days)))
          (PP (IN post)
            (NP (NN stimulation))))))
    (. .)))

(
  (S
    (S
      (NP (NN *))
      (VP (VBZ indicates)
        (NP
          (ADJP (RB statistically) (JJ significant))
          (NN difference))
        (PP (IN with)
          (NP (DT a) (NN p) (NN <) (CD 0.05)))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 2) (: :) (NN ITK))
      (VP (VBZ regulates)
        (NP (NN IL-2) (NN secretion))
        (ADVP (FW in) (FW vitro))
        (PP (IN in) (NN response) (TO to)
          (NP (NN SEB)))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP
            (NP (NNS Splenocytes))
            (CC and)
            (NP
              (NP (NN lymph) (NN node))
              (NNS cells)))
          (PP (IN from)
            (NP
              (ADJP
                (ADJP (JJ WT))
                (PRN (-LRB- -LRB-)
                  (NP (JJ filled) (NNS circles))
                  (-RRB- -RRB-))
                (CC or)
                (ADJP (NN ITK) (JJ deficient))
                (PRN (-LRB- -LRB-)
                  (NP (JJ open) (NNS circles))
                  (-RRB- -RRB-)))
              (NNS mice))))
        (VP (VBD were)
          (VP (VBN stimulated)
            (ADVP (FW in) (FW vitro))
            (PP (IN with)
              (NP
                (NP (DT the) (VBN indicated) (NNS concentrations))
                (PP (IN of)
                  (NP (NN SEB))))))))
      (CC and)
      (S
        (NP
          (NP (NN IL-2) (NNS levels))
          (VP (VBN secreted)
            (PP (IN in)
              (NP (NNS supernatants)))))
        (VP (VBN determined))))
    (. .)))

(
  (S
    (NP
      (NP
        (LST (LS a) (-RRB- -RRB-))
        (NN Time) (NN course))
      (PP (IN of)
        (NP (NN IL-2) (NN secretion)))
      (PP (IN at)
        (NP
          (ADJP (CD 5) (NN μg/ml))
          (NN SEB) (NN dose)))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NN b) (-RRB- -RRB-) (NN IL-2) (NN secretion))
        (IN over) (DT the))
      (VP (VBD indicated)
        (NP
          (NP (NNS times))
          (CC and)
          (NP (NNS doses)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-))
          (NP (NN Day) (CD 1))
          (: ;)
          (NP
            (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-))
            (NP (NN Day) (CD 2)))
          (: ;)
          (NP
            (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-))
            (NP (NN Day) (CD 3)))
          (: ;)
          (NP
            (LST (-LRB- -LRB-) (LS iv) (-RRB- -RRB-))
            (NP (NN Day) (CD 4))
            (CC and)
            (NP
              (LST (-LRB- -LRB-) (LS v) (-RRB- -RRB-))
              (NN Day) (CD 5.))))
        (NN *))
      (VP (VBZ indicates)
        (NP
          (ADJP (RB statistically) (JJ significant))
          (NN difference))
        (PP (IN with)
          (NP (DT a) (NN p) (NN <) (CD 0.05)))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 3))
      (: :)
      (S
        (VP (VBN Reduced)
          (NP (NN T) (NN cell) (NN expansion))
          (PP (IN in) (NN response) (TO to)
            (NP (NN SEB) (NN exposure)))
          (ADVP (FW in) (FW vivo)))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT a) (-RRB- -RRB-) (NN WT)
            (PRN (-LRB- -LRB-)
              (NP (JJ filled) (NNS circles))
              (-RRB- -RRB-))
            (CC or)
            (NN ITK) (JJ deficient) (NNS mice))
          (PRN (-LRB- -LRB-)
            (NP (JJ open) (NNS circles))
            (-RRB- -RRB-)))
        (VP (VBD were)
          (VP (VBN injected)
            (PP (IN with)
              (NP (CD 50) (NN μg) (NN SEB)))
            (ADVP (RB i.p.)))))
      (CC and)
      (S
        (NP (JJ peripheral) (NN blood) (NNS lymphocytes))
        (VP (VBN analyzed)
          (PP (IN after)
            (NP
              (NP
                (QP (CD 2) (, ,) (CD 4)
                  (CC and)
                  (CD 5))
                (NNS days))
              (PP (IN as)
                (PP (IN in)
                  (NP
                    (NP
                      (NP (DT the) (NNS materials))
                      (CC and)
                      (NP (NNS methods)))
                    (PP (IN for)
                      (NP
                        (NP (DT the) (NN percentage))
                        (PP (IN of)
                          (NP (NN Vβ8+CD4+) (NN T) (NNS cells))))))))))
          (SBAR (IN as)
            (S
              (VP (VBN indicated)
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (NN Vβ6+CD4+) (NN T) (NNS cells))
                    (VP (VBD showed)
                      (NP (DT no) (NN change))
                      (, ,)
                      (S
                        (NP (NNS data))
                        (VP (RB not) (VBN shown)))))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (LST (LS b) (-RRB- -RRB-))
      (NP
        (NP (DT The) (JJ same) (NNS data))
        (VP (VBN plotted)
          (PP (IN as)
            (NP (NN fold)))))
      (VP (VBP increase)
        (PP (IN in)
          (NP
            (NP (NN percentage))
            (PP (IN of)
              (NP
                (NP (NN Vβ8+CD4+) (NN T) (NNS cells))
                (PP (IN in)
                  (NP (JJ peripheral) (NN blood)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN *))
      (VP (VBZ indicates)
        (NP
          (NP (DT a)
            (ADJP (RB statistically) (JJ significant))
            (NN difference))
          (PP (IN with)
            (NP (DT a) (NN p) (NN <) (CD 0.05))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN Figure) (CD 4))
          (: :)
          (NP (NN ITK)))
        (JJ null) (NNS mice))
      (VP (VBP secrete)
        (NP (RBR less) (NN IL-2))
        (PP (IN in)
          (NP
            (NP (NN response))
            (PP (TO to)
              (NP (NN SEB) (NN exposure)))
            (ADVP (FW in) (FW vivo))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP
            (NP (NN WT))
            (PRN (-LRB- -LRB-)
              (NP (JJ filled) (NNS circles))
              (-RRB- -RRB-)))
          (CC and)
          (NP (NN ITK)))
        (ADJP (JJ deficient))
        (PRN (-LRB- -LRB-)
          (NP (JJ open) (NNS circles))
          (-RRB- -RRB-))
        (NNS mice))
      (VP (VBD were)
        (VP (VBN injected)
          (PRT (RP i.v.))
          (PP (IN with)
            (NP
              (NP
                (NP
                  (ADJP (CD 50) (NN μg))
                  (NN SEB))
                (CC and)
                (NP (NN blood)))
              (VP (VBN sampled)
                (PP (IN after)
                  (NP
                    (QP (CD 1) (, ,) (CD 2) (, ,) (CD 4) (, ,) (CD 8) (, ,) (CD 12)
                      (CC and)
                      (CD 24))
                    (NNS hrs)))))))))
    (. .)))

(
  (S
    (PP (IN post)
      (NP (NN injection)))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN IL-2))
        (PP (IN in)
          (NP (NN serum))))
      (VP (VBD was)
        (VP (VBN determined)
          (PP (IN by)
            (NP (NN ELISA))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 5))
      (: :)
      (S
        (NP (NN SEB))
        (VP (VBZ induces)
          (NP
            (NP (NN activation))
            (PP (IN of)
              (NP (DT the) (NN JNK) (NN pathway))))
          (ADVP (RB specifically))
          (PP (IN in)
            (NP (VBG responding) (NN T) (NNS cells)))
          (ADVP (FW in) (FW vivo))))
      (. .))))

(
  (S
    (S
      (NP (NN WT) (NNS mice))
      (VP (VBD were)
        (VP
          (VP (VBN injected)
            (PP (IN with)
              (NP
                (NP
                  (ADJP (CD 50) (NN μg))
                  (NN SEB))
                (CC or)
                (NP (JJ PBS) (NN i.v.)))))
          (CC and)
          (VP (VBN sacrificed)
            (PP (IN after)
              (NP (CD 1) (NN hr)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Spleen))
        (CC and)
        (NP (NN lymph) (NNS nodes)))
      (VP (VBD were)
        (VP
          (VP (VBN harvested))
          (CC and)
          (VP (VBN analyzed)
            (PP (IN for)
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP (VBN phosphorylated) (NN c-jun)))
                (PP (IN in)
                  (NP (DT the)
                    (ADJP
                      (ADJP (JJ Vβ8+))
                      (CC and)
                      (ADJP (JJ Vβ6+)))
                    (NN T) (NN cell) (NNS populations)))))))))
    (. .)))

(
  (S
    (S
      (LST (LS a) (-RRB- -RRB-))
      (NP (NN Spleen))
      (: :)
      (NP
        (NP
          (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-))
          (NN phosphorylation))
        (PP (IN of)
          (NP (NN c-jun)))
        (PP (IN in)
          (NP
            (NP (JJ Vβ6+) (NN T) (NNS cells))
            (PP (IN from)
              (NP (JJ PBS) (VBN injected) (NNS mice)))))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-))
      (NP
        (NP (NN phosphorylation))
        (PP (IN of)
          (NP (NN c-jun)))
        (PP (IN in)
          (NP
            (NP (JJ Vβ6+) (NN T) (NNS cells))
            (PP (IN from)
              (NP
                (NP (NN SEB))
                (VBN injected) (NNS mice)))))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-))
      (NP
        (NP (NN phosphorylation))
        (PP (IN of)
          (NP (NN c-jun)))
        (PP (IN in)
          (NP
            (NP (NN Vβ8+) (NN T) (NNS cells))
            (PP (IN from)
              (NP (DT the) (JJ same) (NNS PBS))))))
      (VP (VBN injected)
        (NP (NNS mice))
        (PP (IN in)
          (NP (-LRB- -LRB-) (NN i) (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS iv) (-RRB- -RRB-))
      (NP
        (NP (NN phosphorylation) (NN c-jun))
        (PP (IN in)
          (NP
            (NP (JJ Vβ8+) (NN T) (NNS cells))
            (PP (IN from)
              (NP (DT the) (JJ same) (NN SEB))))))
      (VP (VBN injected)
        (NP (NNS mice))
        (PP (IN in)
          (NP (-LRB- -LRB-) (NN ii) (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (NP
      (NP
        (LST (LS b) (-RRB- -RRB-))
        (NN Lymph) (NN Node))
      (: :)
      (NP
        (NP
          (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-))
          (NN phosphorylation))
        (PP (IN of)
          (NP (NN c-jun)))
        (PP (IN in)
          (NP
            (NP (JJ Vβ6+) (NN T) (NNS cells))
            (PP (IN from)
              (NP (JJ PBS) (VBN injected) (NNS mice))))))
      (. .))))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-))
      (NP
        (NP (NN phosphorylation))
        (PP (IN of)
          (NP (NN c-jun)))
        (PP (IN in)
          (NP
            (NP (JJ Vβ6+) (NN T) (NNS cells))
            (PP (IN from)
              (NP
                (NP (NN SEB))
                (VBN injected) (NNS mice)))))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-))
      (NP
        (NP (NN phosphorylation))
        (PP (IN of)
          (NP (NN c-jun)))
        (PP (IN in)
          (NP
            (NP (NN Vβ8+) (NN T) (NNS cells))
            (PP (IN from)
              (NP (DT the) (JJ same) (NNS PBS))))))
      (VP (VBN injected)
        (NP (NNS mice))
        (PP (IN in)
          (NP (-LRB- -LRB-) (NN i) (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS iv) (-RRB- -RRB-))
      (NP
        (NP (NN phosphorylation) (NN c-jun))
        (PP (IN in)
          (NP
            (NP (JJ Vβ8+) (NN T) (NNS cells))
            (PP (IN from)
              (NP (DT the) (JJ same) (NN SEB))))))
      (VP (VBN injected)
        (NP (NNS mice))
        (PP (IN in)
          (NP (-LRB- -LRB-) (NN ii) (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP (NN Arrow))
      (VP (VBZ points)
        (PP (TO to)
          (NP
            (NP (DT the) (NN population))
            (PP (IN of)
              (NP
                (NP (NNS cells))
                (VP (VBG responding)
                  (PP (TO to)
                    (NP
                      (NP (NN SEB) (NN stimulation))
                      (PP (IN by)
                        (NP
                          (NP (NN activation))
                          (PP (IN of)
                            (NP (DT the) (NN JNK) (NN pathway)))
                          (PP (IN by)
                            (S
                              (VP (VBG inducing)
                                (NP (NN c-jun) (NN phosphorylation))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 6) (: :) (NN ITK))
      (VP (VBZ is)
        (VP (VBN required)
          (PP (IN for)
            (NP
              (NP (NN SEB) (VBD mediated) (NN induction))
              (PP (IN of)
                (NP (NN c-jun) (NN phosphorylation)))
              (PP (IN in)
                (NP (VBG responding) (NN T) (NNS cells)))))
          (ADVP (FW in) (FW vivo)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP
            (NP (NN WT))
            (PRN (-LRB- -LRB-)
              (NP (NN top) (NNS panels))
              (-RRB- -RRB-)))
          (CC or)
          (NP (NN ITK)))
        (JJ null)
        (PRN (-LRB- -LRB-)
          (NP (JJ bottom) (NNS panels))
          (-RRB- -RRB-))
        (NNS mice))
      (VP (VBD were)
        (VP
          (VP (VBN injected)
            (PP (IN with)
              (NP
                (NP
                  (ADJP (CD 50) (NN μg))
                  (NN SEB))
                (CC or)
                (NP (JJ PBS) (NN i.v.)))))
          (CC and)
          (VP (VBN sacrificed)
            (PP (IN after)
              (NP (CD 1) (NN hr)))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Splenocytes))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN analyzed)
          (PP (IN for)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (VBN phosphorylated) (NN c-jun)))
              (PP (IN in)
                (NP (DT the)
                  (ADJP
                    (ADJP (JJ Vβ8+))
                    (CC and)
                    (ADJP (JJ Vβ6+)))
                  (NN T) (NN cell) (NNS populations))))))))
    (. .)))

(
  (S
    (S
      (LST (LS a) (-RRB- -RRB-))
      (NP
        (NP (JJ Vβ6+) (NN T) (NNS cells))
        (PP (IN from)
          (NP (JJ WT) (NNS mice))))
      (: ;)
      (S
        (LST (LS b) (-RRB- -RRB-))
        (VP (JJ Vβ8+)
          (NP
            (NP (NN T) (NNS cells))
            (PP (IN from)
              (NP (JJ WT) (NNS mice))))))
      (: ;)
      (LST (LS c) (-RRB- -RRB-))
      (S
        (VP (JJ Vβ6+)
          (NP
            (NP (NN T) (NNS cells))
            (PP (IN from)
              (NP (NN ITK) (JJ null) (NNS mice))))))
      (: ;)
      (LST (LS d) (-RRB- -RRB-))
      (NP
        (NP (NN Vβ8+) (NN T) (NNS cells))
        (PP (IN from)
          (NP (NN ITK) (JJ null) (NNS mice)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Figure) (CD 7))
        (: :)
        (S
          (NP (NN ITK))
          (VP (VBZ is) (RB not)
            (ADJP (JJ necessary)
              (PP (IN for)
                (NP (NN SEB)))))))
      (VP (VBD induced)
        (NP
          (NP (NN upregulation))
          (PP (IN of)
            (NP (NN CD69) (JJ inresponding) (NN T) (NNS cells))))
        (ADVP (FW in) (FW vivo))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP
            (NP (NN WT))
            (PRN (-LRB- -LRB-)
              (NP (NN top) (NNS panels))
              (-RRB- -RRB-)))
          (CC or)
          (NP (NN ITK)))
        (JJ null)
        (PRN (-LRB- -LRB-)
          (NP (JJ bottom) (NNS panels))
          (-RRB- -RRB-))
        (NNS mice))
      (VP (VBD were)
        (VP
          (VP (VBN injected)
            (PP (IN with)
              (NP
                (NP
                  (ADJP (CD 50) (NN μg))
                  (NN SEB))
                (CC or)
                (NP (JJ PBS) (NN i.v.)))))
          (CC and)
          (VP (VBN sacrificed)
            (PP (IN after)
              (NP (CD 2) (NNS hrs)))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Splenocytes))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN analyzed)
          (PP (IN for)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (NN CD69)))
              (PP (IN on)
                (NP (DT the)
                  (ADJP
                    (ADJP (JJ Vβ8+))
                    (CC and)
                    (ADJP (JJ Vβ6+)))
                  (NN T) (NN cell) (NNS populations))))))))
    (. .)))

(
  (S
    (S
      (LST (LS a) (-RRB- -RRB-))
      (NP
        (NP (JJ Vβ6+) (NN T) (NNS cells))
        (PP (IN from)
          (NP (JJ WT) (NNS mice))))
      (: ;)
      (S
        (LST (LS b) (-RRB- -RRB-))
        (VP (JJ Vβ8+)
          (NP
            (NP (NN T) (NNS cells))
            (PP (IN from)
              (NP (JJ WT) (NNS mice))))))
      (: ;)
      (LST (LS c) (-RRB- -RRB-))
      (S
        (VP (JJ Vβ6+)
          (NP
            (NP (NN T) (NNS cells))
            (PP (IN from)
              (NP (NN ITK) (JJ null) (NNS mice))))))
      (: ;)
      (LST (LS d) (-RRB- -RRB-))
      (NP
        (NP (NN Vβ8+) (NN T) (NNS cells))
        (PP (IN from)
          (NP (NN ITK) (JJ null) (NNS mice)))))
    (. .)))

(
  (S
    (NP
      (NP (NN Table) (CD 1))
      (: :)
      (NP
        (NP (NN Effect))
        (PP (IN of)
          (NP (NN SEB)))
        (PP (IN on)
          (NP
            (NP
              (NP (NN health))
              (CC and)
              (NP (NN survival)))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN WT))
                  (CC and)
                  (NP (NN ITK)))
                (JJ null) (NNS mice))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NNS Mice))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NN WT))
            (CC or)
            (NP (NN ITK) (NN null)))
          (-RRB- -RRB-)))
      (VP (VBD were)
        (VP (VBN injected)
          (PP (IN with)
            (NP
              (NP (DT the) (VBN indicated) (NN amount))
              (PP (IN of)
                (NP (NN LPS)))))
          (, ,)
          (S
            (VP (VBN followed)
              (ADVP
                (NP (CD 4) (NNS hours))
                (RB later))
              (PP (IN by)
                (NP
                  (NP
                    (ADJP (CD 50) (NN μg))
                    (NN SEB))
                  (, ,)
                  (CC both)
                  (NP (VBN delivered) (NN Ip)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Alternatively))
      (, ,)
      (NP (NNS mice))
      (VP (VBD were)
        (VP (VBN injected)
          (PP (IN with)
            (NP (CD 20) (NN mg))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN D-Gal))
        (CC and)
        (NP
          (ADJP (CD 50) (NN μg))
          (NN SEB)))
      (PP (IN at)
        (NP (DT the) (JJ same) (NN time))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS injections))
      (VP (VBD were)
        (VP (VBN delivered)
          (ADVP (RB intraperitoneally)))))
    (. .)))

(
  (S
    (S
      (NP (NNS Mice))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN monitored)
          (PP (IN for)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (VBN ruffled) (NN fur)))))
          (, ,)
          (S
            (ADJP (JJ mucous)
              (PP (IN in)
                (NP
                  (NP (NN feces))
                  (CC and)
                  (NP (NN lethargy)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN *) (NNS mice))
      (VP
        (VP (VBD had)
          (NP
            (NP (JJ ruffled) (NN fur))
            (, ,)
            (NP (NN mucous)))
          (PP (IN in)
            (NP (NNS feces))))
        (CC and)
        (VP (VBD were)
          (ADJP (JJ lethargic)))))
    (. .)))

(
  (S
    (S
      (NP (NN **) (NN mouse))
      (VP (VBD died)
        (PP (IN over)
          (NP
            (NP (DT the) (NN course))
            (PP (IN of)
              (NP (DT the) (NN experiment)))))))
    (. .)))

(
  (S
    (S
      (NP (NN ***) (NN mouse))
      (VP (VBD had)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN euthanized)
                (PP (JJ due) (TO to)
                  (NP
                    (NP (NN severity))
                    (PP (IN of)
                      (NP (NN sickness)))))))))))
    (. .)))

